{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\pchok\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      ">>> ChromaDB collection already has 10 documents.\n",
      "Skipping PubMed fetch, using existing data.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use cpu\n",
      "c:\\Users\\pchok\\anaconda3\\Lib\\site-packages\\transformers\\pipelines\\question_answering.py:391: FutureWarning: Passing a list of SQuAD examples to the pipeline is deprecated and will be removed in v5. Inputs should be passed using the `question` and `context` keyword arguments instead.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Using device=-1 ('cuda:0' if 0, 'cpu' if -1)\n",
      "\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40010238', '40013176', '40012625', '40009619', '40014274']], 'embeddings': None, 'documents': [['Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?']], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}]], 'distances': [[1.0790168919948269, 1.2550644061474616, 1.312107082069278, 1.4452440248055791, 1.459117610810022]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40010238', '40013176', '40012625', '40009619', '40014274', '40010810', '40012602', '40010768', '40013049', '40011748']], 'embeddings': None, 'documents': [['Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\"]], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'title': 'Design and methods of the research unit 5187 PREACT (towards precision psychotherapy for non-respondent patients: from signatures to predictions to clinical utility) - a study protocol for a multicentre observational study in outpatient clinics.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", 'title': 'CD47 as a potential predictive biomarker in colorectal cancer.'}, {'abstract': 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', 'title': 'Weaving oral health provider perspectives to guide future dental therapy advocacy and implementation efforts.'}, {'abstract': \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'title': 'Structure and function of a broad-range thermal receptor in myriapods.'}]], 'distances': [[1.0790168919948269, 1.2550644061474616, 1.312107082069278, 1.4452440248055791, 1.459117610810022, 1.5881020633523484, 1.6910643249445783, 1.7522104905243627, 1.7768618911845657, 1.8410356587571681]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40010238', '40013176', '40009619', '40012625', '40014274']], 'embeddings': None, 'documents': [['Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?']], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}]], 'distances': [[0.9234680548185215, 1.1714080812069738, 1.2857911588756072, 1.3680483216654802, 1.4277947215166231]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40010238', '40013176', '40009619', '40012625', '40014274', '40012602', '40010810', '40010768', '40013049', '40011748']], 'embeddings': None, 'documents': [['Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\"]], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'title': 'Design and methods of the research unit 5187 PREACT (towards precision psychotherapy for non-respondent patients: from signatures to predictions to clinical utility) - a study protocol for a multicentre observational study in outpatient clinics.'}, {'abstract': \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", 'title': 'CD47 as a potential predictive biomarker in colorectal cancer.'}, {'abstract': 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', 'title': 'Weaving oral health provider perspectives to guide future dental therapy advocacy and implementation efforts.'}, {'abstract': \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'title': 'Structure and function of a broad-range thermal receptor in myriapods.'}]], 'distances': [[0.9234680548185215, 1.1714080812069738, 1.2857911588756072, 1.3680483216654802, 1.4277947215166231, 1.5785842388932936, 1.6589908073950865, 1.8367015946399419, 1.8950247378804226, 2.1315760049637684]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40010238', '40012602', '40012625', '40014274', '40013176']], 'embeddings': None, 'documents': [['Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.']], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}]], 'distances': [[1.2066698422315638, 1.2291575110335835, 1.2338591163129322, 1.322467760067934, 1.37552730235613]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40010238', '40012602', '40012625', '40014274', '40013176', '40009619', '40010810', '40013049', '40010768', '40011748']], 'embeddings': None, 'documents': [['Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\"]], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}, {'abstract': 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'title': 'Design and methods of the research unit 5187 PREACT (towards precision psychotherapy for non-respondent patients: from signatures to predictions to clinical utility) - a study protocol for a multicentre observational study in outpatient clinics.'}, {'abstract': 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', 'title': 'Weaving oral health provider perspectives to guide future dental therapy advocacy and implementation efforts.'}, {'abstract': \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", 'title': 'CD47 as a potential predictive biomarker in colorectal cancer.'}, {'abstract': \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'title': 'Structure and function of a broad-range thermal receptor in myriapods.'}]], 'distances': [[1.2066698422315638, 1.2291575110335835, 1.2338591163129322, 1.322467760067934, 1.37552730235613, 1.4866929412228929, 1.5117504288522698, 1.6500137770084589, 1.8131157017239898, 2.2308064052789462]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40010238', '40012602', '40014274', '40009619', '40013176']], 'embeddings': None, 'documents': [['Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.']], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}]], 'distances': [[1.23257521973374, 1.5386213692213084, 1.594994818073389, 1.6215053067982486, 1.641633322652963]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40010238', '40012602', '40014274', '40009619', '40013176', '40012625', '40010810', '40013049', '40010768', '40011748']], 'embeddings': None, 'documents': [['Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\"]], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}, {'abstract': 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'title': 'Design and methods of the research unit 5187 PREACT (towards precision psychotherapy for non-respondent patients: from signatures to predictions to clinical utility) - a study protocol for a multicentre observational study in outpatient clinics.'}, {'abstract': 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', 'title': 'Weaving oral health provider perspectives to guide future dental therapy advocacy and implementation efforts.'}, {'abstract': \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", 'title': 'CD47 as a potential predictive biomarker in colorectal cancer.'}, {'abstract': \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'title': 'Structure and function of a broad-range thermal receptor in myriapods.'}]], 'distances': [[1.23257521973374, 1.5386213692213084, 1.594994818073389, 1.6215053067982486, 1.641633322652963, 1.6721170598843607, 1.7590949890746772, 1.8819896938651373, 1.8854906402621028, 2.018798323743472]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40013176', '40010238', '40014274', '40012602', '40009619']], 'embeddings': None, 'documents': [['To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.']], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}]], 'distances': [[1.0046287450777378, 1.117722655790584, 1.2514549947311078, 1.3504106196623502, 1.3727184167283493]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40013176', '40010238', '40014274', '40012602', '40009619', '40012625', '40010810', '40013049', '40010768', '40011748']], 'embeddings': None, 'documents': [['To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\"]], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}, {'abstract': 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'title': 'Design and methods of the research unit 5187 PREACT (towards precision psychotherapy for non-respondent patients: from signatures to predictions to clinical utility) - a study protocol for a multicentre observational study in outpatient clinics.'}, {'abstract': 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', 'title': 'Weaving oral health provider perspectives to guide future dental therapy advocacy and implementation efforts.'}, {'abstract': \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", 'title': 'CD47 as a potential predictive biomarker in colorectal cancer.'}, {'abstract': \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'title': 'Structure and function of a broad-range thermal receptor in myriapods.'}]], 'distances': [[1.0046287450777378, 1.117722655790584, 1.2514549947311078, 1.3504106196623502, 1.3727184167283493, 1.3808974264438596, 1.483912427094187, 1.5791933026075307, 1.7855490674688592, 2.3299555404805727]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "--- RESULTS FOR 5 EXAMPLE QUERIES (TABLE) ---\n",
      "\n",
      "                                             question retrieval_method  top_k  \\\n",
      "0                 How does AI help in drug discovery?             bm25      5   \n",
      "1                 How does AI help in drug discovery?             bm25     10   \n",
      "2                 How does AI help in drug discovery?            dense      5   \n",
      "3                 How does AI help in drug discovery?            dense     10   \n",
      "4                    How does AI help in diagnostics?             bm25      5   \n",
      "5                    How does AI help in diagnostics?             bm25     10   \n",
      "6                    How does AI help in diagnostics?            dense      5   \n",
      "7                    How does AI help in diagnostics?            dense     10   \n",
      "8   What are the benefits of machine learning in h...             bm25      5   \n",
      "9   What are the benefits of machine learning in h...             bm25     10   \n",
      "10  What are the benefits of machine learning in h...            dense      5   \n",
      "11  What are the benefits of machine learning in h...            dense     10   \n",
      "12      How is deep learning used in medical imaging?             bm25      5   \n",
      "13      How is deep learning used in medical imaging?             bm25     10   \n",
      "14      How is deep learning used in medical imaging?            dense      5   \n",
      "15      How is deep learning used in medical imaging?            dense     10   \n",
      "16  Does artificial intelligence improve patient o...             bm25      5   \n",
      "17  Does artificial intelligence improve patient o...             bm25     10   \n",
      "18  Does artificial intelligence improve patient o...            dense      5   \n",
      "19  Does artificial intelligence improve patient o...            dense     10   \n",
      "\n",
      "                                               answer  token_length  \\\n",
      "0     streamlining logistics and inventory management             5   \n",
      "1     streamlining logistics and inventory management             5   \n",
      "2                       enhance vaccine supply chains             4   \n",
      "3                             artificial intelligence             2   \n",
      "4     streamlining logistics and inventory management             5   \n",
      "5     streamlining logistics and inventory management             5   \n",
      "6     streamlining logistics and inventory management             5   \n",
      "7                             artificial intelligence             2   \n",
      "8   negatively affects patient outcomes, wait time...             9   \n",
      "9   negatively affects patient outcomes, wait time...             9   \n",
      "10                                       transparency             1   \n",
      "11                 greater oral healthcare inequities             4   \n",
      "12  magnetic resonance imaging and cerebrospinal f...             7   \n",
      "13  predictive analytics with interpretable rule-b...             6   \n",
      "14                 Artificial Intelligence (AI) tools             4   \n",
      "15                 Artificial Intelligence (AI) tools             4   \n",
      "16          improve the management of this population             6   \n",
      "17          improve the management of this population             6   \n",
      "18         improve the management of this population?             6   \n",
      "19         improve the management of this population?             6   \n",
      "\n",
      "    contains_answer  confidence_score  \n",
      "0              True          0.422561  \n",
      "1              True          0.422561  \n",
      "2              True          0.316537  \n",
      "3              True          0.729459  \n",
      "4              True          0.489828  \n",
      "5              True          0.489828  \n",
      "6              True          0.393711  \n",
      "7              True          0.355121  \n",
      "8              True          0.283635  \n",
      "9              True          0.283635  \n",
      "10             True          0.319089  \n",
      "11             True          0.375713  \n",
      "12             True          0.072802  \n",
      "13             True          0.201579  \n",
      "14             True          0.253473  \n",
      "15             True          0.253473  \n",
      "16             True          0.180981  \n",
      "17             True          0.180981  \n",
      "18             True          0.089209  \n",
      "19             True          0.089209  \n",
      "\n",
      "--- DETAILED PRINT OF Q&A ---\n",
      "\n",
      "Q: How does AI help in drug discovery?\n",
      "Method=bm25 | top_k=5\n",
      "Answer: streamlining logistics and inventory management\n",
      "Token Length: 5, Contains Answer: True, Confidence: 0.423\n",
      "------------------------------------------------------------\n",
      "Q: How does AI help in drug discovery?\n",
      "Method=bm25 | top_k=10\n",
      "Answer: streamlining logistics and inventory management\n",
      "Token Length: 5, Contains Answer: True, Confidence: 0.423\n",
      "------------------------------------------------------------\n",
      "Q: How does AI help in drug discovery?\n",
      "Method=dense | top_k=5\n",
      "Answer: enhance vaccine supply chains\n",
      "Token Length: 4, Contains Answer: True, Confidence: 0.317\n",
      "------------------------------------------------------------\n",
      "Q: How does AI help in drug discovery?\n",
      "Method=dense | top_k=10\n",
      "Answer: artificial intelligence\n",
      "Token Length: 2, Contains Answer: True, Confidence: 0.729\n",
      "------------------------------------------------------------\n",
      "Q: How does AI help in diagnostics?\n",
      "Method=bm25 | top_k=5\n",
      "Answer: streamlining logistics and inventory management\n",
      "Token Length: 5, Contains Answer: True, Confidence: 0.490\n",
      "------------------------------------------------------------\n",
      "Q: How does AI help in diagnostics?\n",
      "Method=bm25 | top_k=10\n",
      "Answer: streamlining logistics and inventory management\n",
      "Token Length: 5, Contains Answer: True, Confidence: 0.490\n",
      "------------------------------------------------------------\n",
      "Q: How does AI help in diagnostics?\n",
      "Method=dense | top_k=5\n",
      "Answer: streamlining logistics and inventory management\n",
      "Token Length: 5, Contains Answer: True, Confidence: 0.394\n",
      "------------------------------------------------------------\n",
      "Q: How does AI help in diagnostics?\n",
      "Method=dense | top_k=10\n",
      "Answer: artificial intelligence\n",
      "Token Length: 2, Contains Answer: True, Confidence: 0.355\n",
      "------------------------------------------------------------\n",
      "Q: What are the benefits of machine learning in healthcare?\n",
      "Method=bm25 | top_k=5\n",
      "Answer: negatively affects patient outcomes, wait times, and resource efficiency\n",
      "Token Length: 9, Contains Answer: True, Confidence: 0.284\n",
      "------------------------------------------------------------\n",
      "Q: What are the benefits of machine learning in healthcare?\n",
      "Method=bm25 | top_k=10\n",
      "Answer: negatively affects patient outcomes, wait times, and resource efficiency\n",
      "Token Length: 9, Contains Answer: True, Confidence: 0.284\n",
      "------------------------------------------------------------\n",
      "Q: What are the benefits of machine learning in healthcare?\n",
      "Method=dense | top_k=5\n",
      "Answer: transparency\n",
      "Token Length: 1, Contains Answer: True, Confidence: 0.319\n",
      "------------------------------------------------------------\n",
      "Q: What are the benefits of machine learning in healthcare?\n",
      "Method=dense | top_k=10\n",
      "Answer: greater oral healthcare inequities\n",
      "Token Length: 4, Contains Answer: True, Confidence: 0.376\n",
      "------------------------------------------------------------\n",
      "Q: How is deep learning used in medical imaging?\n",
      "Method=bm25 | top_k=5\n",
      "Answer: magnetic resonance imaging and cerebrospinal fluid analysis\n",
      "Token Length: 7, Contains Answer: True, Confidence: 0.073\n",
      "------------------------------------------------------------\n",
      "Q: How is deep learning used in medical imaging?\n",
      "Method=bm25 | top_k=10\n",
      "Answer: predictive analytics with interpretable rule-based methods\n",
      "Token Length: 6, Contains Answer: True, Confidence: 0.202\n",
      "------------------------------------------------------------\n",
      "Q: How is deep learning used in medical imaging?\n",
      "Method=dense | top_k=5\n",
      "Answer: Artificial Intelligence (AI) tools\n",
      "Token Length: 4, Contains Answer: True, Confidence: 0.253\n",
      "------------------------------------------------------------\n",
      "Q: How is deep learning used in medical imaging?\n",
      "Method=dense | top_k=10\n",
      "Answer: Artificial Intelligence (AI) tools\n",
      "Token Length: 4, Contains Answer: True, Confidence: 0.253\n",
      "------------------------------------------------------------\n",
      "Q: Does artificial intelligence improve patient outcomes?\n",
      "Method=bm25 | top_k=5\n",
      "Answer: improve the management of this population\n",
      "Token Length: 6, Contains Answer: True, Confidence: 0.181\n",
      "------------------------------------------------------------\n",
      "Q: Does artificial intelligence improve patient outcomes?\n",
      "Method=bm25 | top_k=10\n",
      "Answer: improve the management of this population\n",
      "Token Length: 6, Contains Answer: True, Confidence: 0.181\n",
      "------------------------------------------------------------\n",
      "Q: Does artificial intelligence improve patient outcomes?\n",
      "Method=dense | top_k=5\n",
      "Answer: improve the management of this population?\n",
      "Token Length: 6, Contains Answer: True, Confidence: 0.089\n",
      "------------------------------------------------------------\n",
      "Q: Does artificial intelligence improve patient outcomes?\n",
      "Method=dense | top_k=10\n",
      "Answer: improve the management of this population?\n",
      "Token Length: 6, Contains Answer: True, Confidence: 0.089\n",
      "------------------------------------------------------------\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- INTERACTIVE MODE (TEST ALL COMBOS) ---\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\pchok\\anaconda3\\Lib\\site-packages\\transformers\\pipelines\\question_answering.py:391: FutureWarning: Passing a list of SQuAD examples to the pipeline is deprecated and will be removed in v5. Inputs should be passed using the `question` and `context` keyword arguments instead.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Dense Retrieval Results: {'ids': [['40010810', '40014274', '40012602', '40011748', '40009619']], 'embeddings': None, 'documents': [['Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.']], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'title': 'Design and methods of the research unit 5187 PREACT (towards precision psychotherapy for non-respondent patients: from signatures to predictions to clinical utility) - a study protocol for a multicentre observational study in outpatient clinics.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'title': 'Structure and function of a broad-range thermal receptor in myriapods.'}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}]], 'distances': [[1.4953553151101766, 1.5530663066123587, 1.585206898982912, 1.653272653552641, 1.7357029941169528]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40010810', '40014274', '40012602', '40011748', '40009619', '40010238', '40013176', '40012625', '40010768', '40013049']], 'embeddings': None, 'documents': [['Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.']], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'title': 'Design and methods of the research unit 5187 PREACT (towards precision psychotherapy for non-respondent patients: from signatures to predictions to clinical utility) - a study protocol for a multicentre observational study in outpatient clinics.'}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'title': 'Structure and function of a broad-range thermal receptor in myriapods.'}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}, {'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}, {'abstract': \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", 'title': 'CD47 as a potential predictive biomarker in colorectal cancer.'}, {'abstract': 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', 'title': 'Weaving oral health provider perspectives to guide future dental therapy advocacy and implementation efforts.'}]], 'distances': [[1.4953553151101766, 1.5530663066123587, 1.585206898982912, 1.653272653552641, 1.7357029941169528, 1.7519352714590628, 1.8369070618244867, 1.981735613205737, 1.9849745715106348, 2.0994493376631156]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "--- RESULTS FOR YOUR QUESTION (TABLE) ---\n",
      "\n",
      "                                   question retrieval_method  top_k  \\\n",
      "0  What model is used for metabolics study?             bm25      5   \n",
      "1  What model is used for metabolics study?             bm25     10   \n",
      "2  What model is used for metabolics study?            dense      5   \n",
      "3  What model is used for metabolics study?            dense     10   \n",
      "\n",
      "              answer  token_length  contains_answer  confidence_score  \n",
      "0                 AI             1             True          0.090576  \n",
      "1  predictive models             2             True          0.646343  \n",
      "2  predictive models             2             True          0.007803  \n",
      "3          Biomarker             1             True          0.427688  \n",
      "\n",
      "--- DETAILED PRINT OF Q&A ---\n",
      "\n",
      "Q: What model is used for metabolics study?\n",
      "Method=bm25 | top_k=5\n",
      "Answer: AI\n",
      "Token Length: 1, Contains Answer: True, Confidence: 0.091\n",
      "------------------------------------------------------------\n",
      "Q: What model is used for metabolics study?\n",
      "Method=bm25 | top_k=10\n",
      "Answer: predictive models\n",
      "Token Length: 2, Contains Answer: True, Confidence: 0.646\n",
      "------------------------------------------------------------\n",
      "Q: What model is used for metabolics study?\n",
      "Method=dense | top_k=5\n",
      "Answer: predictive models\n",
      "Token Length: 2, Contains Answer: True, Confidence: 0.008\n",
      "------------------------------------------------------------\n",
      "Q: What model is used for metabolics study?\n",
      "Method=dense | top_k=10\n",
      "Answer: Biomarker\n",
      "Token Length: 1, Contains Answer: True, Confidence: 0.428\n",
      "------------------------------------------------------------\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\pchok\\anaconda3\\Lib\\site-packages\\transformers\\pipelines\\question_answering.py:391: FutureWarning: Passing a list of SQuAD examples to the pipeline is deprecated and will be removed in v5. Inputs should be passed using the `question` and `context` keyword arguments instead.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Dense Retrieval Results: {'ids': [['40010238', '40012602', '40013176', '40014274', '40012625']], 'embeddings': None, 'documents': [['Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\"]], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}]], 'distances': [[1.4388773174672034, 1.5388500494592317, 1.6340451806603273, 1.6510382884706345, 1.6853512970187172]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "Dense Retrieval Results: {'ids': [['40010238', '40012602', '40013176', '40014274', '40012625', '40009619', '40010810', '40010768', '40011748', '40013049']], 'embeddings': None, 'documents': [['Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.']], 'uris': None, 'data': None, 'metadatas': [[{'abstract': 'Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting the central nervous system. MS diagnosis is complex, requiring magnetic resonance imaging and cerebrospinal fluid analysis due to the lack of definitive biomarkers. Although treatment advancements have reduced disability, diagnostic and therapeutic challenges remain, even among MS-specialized neurologists. Artificial Intelligence (AI) tools, which analyze large datasets, are increasingly used in healthcare, especially for diagnosis and treatment.', 'title': 'Artificial intelligence versus neurologists: A comparative study on multiple sclerosis expertise.'}, {'abstract': 'This study aims to address the critical issue of emergency department (ED) overcrowding, which negatively affects patient outcomes, wait times, and resource efficiency. Accurate prediction of ED length of stay (LOS) can streamline operations and improve care delivery. We utilized the MIMIC IV-ED dataset, comprising over 400,000 patient records, to classify ED LOS into short (≤4.5 hours) and long (>4.5 hours) categories. Using machine learning models, including Gradient Boosting (GB), Random Forest (RF), Logistic Regression (LR), and Multilayer Perceptron (MLP), we identified GB as the best performing model outperforming the other models with an AUC of 0.730, accuracy of 69.93%, sensitivity of 88.20%, and specificity of 40.95% on the original dataset. In the balanced dataset, GB had an AUC of 0.729, accuracy of 68.86%, sensitivity of 75.39%, and specificity of 58.59%. To enhance interpretability, a novel rule extraction method for GB model was implemented using relevant important predictors, such as triage acuity, comorbidity scores, and arrival methods. By combining predictive analytics with interpretable rule-based methods, this research provides actionable insights for optimizing patient flow and resource allocation. The findings highlight the importance of transparency in machine learning applications for healthcare, paving the way for future improvements in model performance and clinical adoption.', 'title': 'Leveraging machine learning and rule extraction for enhanced transparency in emergency department length of stay prediction.'}, {'abstract': 'To obtain detailed data on the acceptance of an artificial intelligence chatbot (ChatGPT; OpenAI, San Francisco, CA, USA) in ophthalmology among physicians, a survey explored physician responses regarding using ChatGPT in ophthalmology. The survey included questions about the applications of ChatGPT in ophthalmology, future concerns such as job replacement or automation, research, medical education, patient education, ethical concerns, and implementation in practice. One hundred ninety-nine ophthalmic surgeons participated in this study. Approximately two-thirds of the participants had 15 years or more experience in ophthalmology. One hundred sixteen reported that they had used ChatGPT. We found no difference in age, gender, or level of experience between those who used or did not use ChatGPT. ChatGPT users tend to consider ChatGPT and artificial intelligence (AI)\\xa0as useful in ophthalmology (<i>P</i>=0.001). Both users and non-users think that AI is useful for identifying early signs of eye disease, providing decision support in treatment planning, monitoring patient progress, answering patient questions, and scheduling appointments. Both users and non-users believe there are some issues related to the use of AI in health care, such as liability issues, privacy concerns, accuracy of diagnosis, trust of the chatbot, ethical issues, and information bias. The use of ChatGPT and other forms of AI is increasingly becoming accepted among ophthalmologists. AI is seen as a helpful tool for improving patient education, decision support, and medical services, but there are also concerns regarding privacy and job displacement, which warrant human oversight.', 'title': \"Physicians' Perspectives on ChatGPT in Ophthalmology: Insights on Artificial Intelligence (AI) Integration in Clinical Practice.\"}, {'abstract': 'This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability in health status. The primary research questions are: How can frailty assessment be effectively integrated into diabetes care? What strategies can optimize glycaemic control and outcomes for frail older adults? How can innovative tools and technologies, including artificial intelligence (AI), improve the management of this population?', 'title': 'Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes.'}, {'abstract': \"Examining the current situation of the vaccine supply chain in Africa, the article highlights the importance of AI technologies while outlining the prospects and problems in vaccine supply chain management in Africa. Despite the significance of vaccinations, many African children are unable to receive them due to logistical challenges and a lack of infrastructure. AI has the potential to increase productivity by streamlining logistics and inventory management, but it is hampered by issues with data privacy and technology infrastructure. This perspectiveoffers ways for utilizing AI to enhance vaccine supply chains in Africa, citing successful experiences in Nigeria, Malawi, Rwanda, and Ghana as examples of AI's advantages. In order to improve healthcare outcomes and immunization coverage in Africa, cooperation among stakeholders is stressed.\", 'title': 'Leveraging AI to optimize vaccines supply chain and logistics in Africa: opportunities and challenges.'}, {'abstract': 'Acute kidney injury (AKI) is associated with high mortality rates and long-term adverse outcomes and significantly increases medical costs. The AKI electronic alert system built the AKI diagnostic algorithm into the medical system, along with automated collection of key indications and generation of alerts. However, the relationship between the AKI electronic alert system and medical costs is still unknown.', 'title': 'Non-linear association between AKI alert detection rate by physicians and medical costs.'}, {'abstract': 'Cognitive-behavioural therapy (CBT) works-but not equally well for all patients. Less than 50% of patients with internalising disorders achieve clinically meaningful improvement, with negative consequences for patients and healthcare systems. The research unit (RU) 5187 seeks to improve this situation by an in-depth investigation of the phenomenon of treatment non-response (TNR) to CBT. We aim to identify bio-behavioural signatures associated with TNR, develop predictive models applicable to individual patients and enhance the utility of predictive analytics by collecting a naturalistic cohort with high ecological validity for the outpatient sector.', 'title': 'Design and methods of the research unit 5187 PREACT (towards precision psychotherapy for non-respondent patients: from signatures to predictions to clinical utility) - a study protocol for a multicentre observational study in outpatient clinics.'}, {'abstract': \"In this week's Journal for ImmunoTherapy for Cancer, Arai and colleagues analyzed next-generation sequencing data for DNA and RNA from 14,287 patients with colorectal cancer (CRC) categorized by median CD47 expression level, and showed that CD47, a key component of innate immunity in deflecting phagocytosis, is associated with molecular subtypes of CRC, cell damage-associated molecular pattern-related genes, major oncogenic pathways, and adaptive immune checkpoint genes. Taken together, they concluded that CD47 expression is associated with activation of oncogenic pathways and an immune-engaged tumor microenvironment. Clinical outcomes data also demonstrated that high CD47 is associated with prolonged survival in patients treated with antiangiogenic and checkpoint inhibitor therapy. Biomarker studies such as this will enable broader application of immuno-oncology to patients with CRC and other malignancies.\", 'title': 'CD47 as a potential predictive biomarker in colorectal cancer.'}, {'abstract': \"Broad-range thermal receptor 1 (BRTNaC1), activated by heat at low extracellular pH, was recently identified in myriapods. Although the overexpression of BRTNaC1 leads to robust heat-activated current with a cation selectivity profile, the structure of this receptor and how it is gated by proton and heat remain to be investigated. Here we determine cryogenic electron microscopy structures of BRTNaC1 in the apo, proton-induced and heated states. Based on these structures, patch-clamp recordings and molecular dynamic simulations, we found that a 'twist the wrist' mechanism is used for proton activation of BRTNaC1, while heat induces broad conformational changes in BRTNaC1, including rotation and shift in the transmembrane helices to open this channel. Moreover, as testosterone inhibited BRTNaC1 activation, we identified four clustered residues important for such inhibition. Therefore, our study has established the structural basis for ligand and temperature gating in the BRTNaC1 ion channel.\", 'title': 'Structure and function of a broad-range thermal receptor in myriapods.'}, {'abstract': 'American Indian and Alaska Native (AI/AN) communities in the United States (U.S.) face greater oral healthcare inequities than other groups in the country. A solution to improving oral healthcare access for American Indian and Alaska Native communities in the United States is the integration of dental therapists (DT). However, it has been met with opposition. The goal of this study was to explore oral health provider engagement and perspectives of DT implementation in local communities.', 'title': 'Weaving oral health provider perspectives to guide future dental therapy advocacy and implementation efforts.'}]], 'distances': [[1.4388773174672034, 1.5388500494592317, 1.6340451806603273, 1.6510382884706345, 1.6853512970187172, 1.7059208675206474, 1.7190181082914533, 1.9021348210456583, 1.991160850320692, 2.04093949078809]], 'included': [<IncludeEnum.distances: 'distances'>, <IncludeEnum.documents: 'documents'>, <IncludeEnum.metadatas: 'metadatas'>]}\n",
      "\n",
      "--- RESULTS FOR YOUR QUESTION (TABLE) ---\n",
      "\n",
      "                                            question retrieval_method  top_k  \\\n",
      "0  How can Generative AI help for image classific...             bm25      5   \n",
      "1  How can Generative AI help for image classific...             bm25     10   \n",
      "2  How can Generative AI help for image classific...            dense      5   \n",
      "3  How can Generative AI help for image classific...            dense     10   \n",
      "\n",
      "                                              answer  token_length  \\\n",
      "0  innovative tools and technologies, including a...             7   \n",
      "1  innovative tools and technologies, including a...             7   \n",
      "2  Artificial Intelligence (AI) tools, which anal...             8   \n",
      "3  patch-clamp recordings and molecular dynamic s...             6   \n",
      "\n",
      "   contains_answer  confidence_score  \n",
      "0             True          0.386894  \n",
      "1             True          0.386894  \n",
      "2             True          0.180171  \n",
      "3             True          0.224399  \n",
      "\n",
      "--- DETAILED PRINT OF Q&A ---\n",
      "\n",
      "Q: How can Generative AI help for image classifications?\n",
      "Method=bm25 | top_k=5\n",
      "Answer: innovative tools and technologies, including artificial intelligence\n",
      "Token Length: 7, Contains Answer: True, Confidence: 0.387\n",
      "------------------------------------------------------------\n",
      "Q: How can Generative AI help for image classifications?\n",
      "Method=bm25 | top_k=10\n",
      "Answer: innovative tools and technologies, including artificial intelligence\n",
      "Token Length: 7, Contains Answer: True, Confidence: 0.387\n",
      "------------------------------------------------------------\n",
      "Q: How can Generative AI help for image classifications?\n",
      "Method=dense | top_k=5\n",
      "Answer: Artificial Intelligence (AI) tools, which analyze large datasets\n",
      "Token Length: 8, Contains Answer: True, Confidence: 0.180\n",
      "------------------------------------------------------------\n",
      "Q: How can Generative AI help for image classifications?\n",
      "Method=dense | top_k=10\n",
      "Answer: patch-clamp recordings and molecular dynamic simulations\n",
      "Token Length: 6, Contains Answer: True, Confidence: 0.224\n",
      "------------------------------------------------------------\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA50AAAHWCAYAAAD0LO3MAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjkuMiwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8hTgPZAAAACXBIWXMAAA9hAAAPYQGoP6dpAABr8klEQVR4nO3dZ3gUZf/28XPTQ+gEQguhQ5AqCIQivYRyi1JFpStF4JaISu+KBRFFikoXBFSQLhBa5JYiXRFERZAiEHpPIMn1vODJ/lmygQQyWRK/n+PIAZm2v5lcMzvnzuw1NmOMEQAAAAAAFnBzdQEAAAAAgPSL0AkAAAAAsAyhEwAAAABgGUInAAAAAMAyhE4AAAAAgGUInQAAAAAAyxA6AQAAAACWIXQCAAAAACxD6AQAAAAAWCZZoXPWrFmy2WzauXNnsl/oxo0bGjFihDZt2pTseV3hnXfe0ZIlSxIM37Rpk2w2W5pYj7i4OH355ZeqX7++/P395enpqVy5cqlZs2Zavny54uLiXF2ipe3i6NGjatq0qbJnzy6bzabXXnst0WkLFiyoESNGJBj+119/qXfv3ipevLh8fX2VIUMGPfHEExoyZIhOnjyZ4jXHS4ntcvToUdlsNs2aNSvF6kqO27dvK3fu3LLZbPr2229dUkNqGTFihAoWLJikaYcMGaICBQrIw8NDWbNmtbSux92qVauc7nfSnX2yU6dOqVrP/Tj7GxcsWFDNmjVzOv3OnTtduv89zo4cOaK+ffsqODhYfn5+8vHxUcGCBfXiiy9q48aNMsa4usQUc+DAAY0YMUJHjx5NMK5Tp05JPm5YJSwsTDabLdF2HP8+Mm7cuPsuJ6nTJYdV51upeQweMWKEbDabpa+RFrj6fERyvr9duHBB7dq1U65cuWSz2dSiRQtJks1mS/S9KSU87hnj6NGj6tevn4KDg5UhQwYVLFhQgwYNUnR0tH2a+FqdHdsS42FBrU7duHFDI0eOlCTVrl07tV72ob3zzjtq1aqVvQHGe/LJJ7V161aVKlXKNYUlUVRUlFq0aKG1a9eqXbt2mjJlinLnzq2zZ89q9erVat26tRYuXKhnnnnGpXVa2S769eun7du3a8aMGcqdO7fy5MmTrPlXrFihdu3ayd/fX71791aFChVks9n0yy+/aMaMGVq5cqX27NmTojXHS4ntkidPHm3dulVFihRJwcqSbsWKFTpz5owkafr06WrVqpVL6nicLF26VG+//bYGDx6s0NBQeXt7u7okl1q1apUmTZrk9M39u+++U+bMmVO/KFhq2bJlat++vfz9/dWjRw89+eST8vb21p9//qlvv/1WdevW1bp161SvXj1Xl5oiDhw4oJEjR6p27doJTniHDh2q//73v64pTHc+GJw7d64kafXq1Tp58qTy5cvnsnpSQ2ofg7t166bGjRtb+hpIGmf72+jRo/Xdd99pxowZKlKkiLJnzy5J2rp1q/Lnz29ZLY97xpg1a5a2bdumgQMHqkCBAtq0aZNGjRql69ev6+OPP37o5aZa6LTK7du3ZbPZ5OGROquSOXNmVa1aNVVe61GEhYVpzZo1mj17tjp06OAw7rnnntMbb7yhmzdvuqi61LF//35Vrlw5wU6dFEeOHFG7du1UvHhxbdy4UVmyZLGPq1u3rvr27avvvvsuBatNed7e3i5tq9OnT5eXl5dq1aqltWvX6sSJE5YexF3hxo0bypAhQ5Kn379/vySpb9++ypUrl0tqSCsqVKjg6hKQwg4fPqznn39eTzzxhNatW+fwoUKtWrXUtWtXbdq0SdmyZXNhlfeXkvubqz4QjLd06VKdPXtWTZs21cqVKzV79mwNGjTIpTVZLbWPwfnz509373tplbP9bf/+/SpSpIheeOEFh+GuOnd6XDJGz549HT4Mrl27tnbu3KnFixc/UuiUSYaZM2caSWbHjh32YR07djR+fn7mjz/+MKGhocbPz8/kz5/fhIWFmaioKGOMMUeOHDGSEvx07NjRvpzff//dPP/88yZnzpzGy8vLlCxZ0nz66acOr79x40YjycyZM8eEhYWZvHnzGpvNZg4ePGgiIyNNz549TXBwsPHz8zM5c+Y0derUMT/88EOC9YiKijIjR440JUuWNN7e3iZ79uymdu3a5scffzTmzn09CX5q1arlUMPGjRuNMcZ89NFHRpL5448/ErzOm2++aTw9Pc3Zs2ftw8LDw03dunVNpkyZjK+vr6lWrZpZt25dcv4MD3Tq1Cnj6elpGjVqlOR5/v77b/PCCy84bP9x48aZ2NhY+zT3rnu8+L/vzJkz7cNSql08TK3xdd77c+TIkUSXGRQUZIYPH27/vXfv3kaS2bp1a5K2nzHGTJ8+3ZQtW9Z4e3ubbNmymRYtWpgDBw44TJMS2+WPP/4wnTp1MkWLFjW+vr4mb968plmzZubnn392eC1nf5fhw4cbSWb//v2mXbt2JnPmzCZXrlymc+fO5tKlSw7zf/3116Zy5comc+bMxtfX1xQqVMh07tw5Sdvi5MmTxt3d3bRs2dKsXbvWSDKjR49OMF1Stke8yZMnm7Jlyxo/Pz+TMWNGU6JECTNw4EBjjDGXL1827u7u5v3337dPf/bsWWOz2UzmzJnN7du37cP79Olj/P39TVxcnH1YUvbL+G23a9cu07JlS5M1a1aTO3du+7igoKD7bpOgoKAEf9P4NhcbG2vee+89U6JECePl5WVy5sxpXnrpJXP8+HGHZdSqVcs88cQTJiIiwoSEhBhfX1/Ttm3b+77uzJkzTfHixe37yuzZs03Hjh0d6k3Ovm2MMTt27DDNmzc32bJlM97e3qZ8+fJm4cKFDtNcv37dvP7666ZgwYL2faJixYrmq6++Msbc+dvfbz8NCgpKcCxIynEqvuYPPvjAfPjhh6ZgwYLGz8/PVK1aNVn7872c/Y2DgoJM06ZNnU6/Y8cOp9tu8+bNpm7duiZjxozG19fXhISEmBUrVtjHP2pbdubgwYOmXbt2JleuXMbLy8sEBgaal156yb6PJfX981G3ba9evRKcQyRFcs4PvvrqKzNo0CCTJ08ekylTJlOvXj3z22+/JVjmo+7zO3bsMG3btjVBQUHGx8fHBAUFmXbt2pmjR4/a548/Z7r3J75N3Lsfli9f3tSoUSNBrTExMSZv3rzm2WeftQ+Ljo42o0ePth8z/P39TadOnUxkZGSSt2vjxo2Nl5eXiYyMNIGBgaZo0aIJ2tLdf/P7SW7bSMoxxNlxKf49Y//+/aZu3bomQ4YMxt/f37z66qvm+vXr963RFcfg+DZ0bx1NmzY1y5cvN+XLlzc+Pj6mZMmSZvny5caYO+2mZMmSJkOGDOapp55KsL8kpe3F27x5s6latarx9vY2efPmNUOGDDFffPGF03OiBQsWmKpVq5oMGTIYPz8/07BhQ7N79+77btN4J06cMC+//LLJnz+/8fT0NHny5DEtW7Y0p0+fNsY4fy9J6rlMbGysGT16tClevLjx8fExWbJkMWXKlDETJkywTxMZGWl//fj9oVq1aiY8PNw+zd37W2LnWfFt7e62kdR1vHnzpgkLCzPlypUzmTNnNtmyZTNVq1Y1S5YscVhOcjJGvKVLl5qqVasaX19fkzFjRlO/fn2zZcsWh2msPL+7ffu2KV68uClfvrx9WHyt9zu3vleKhE4vLy8THBxsxo0bZ9atW2eGDRtmbDabGTlypDHmTshbvXq1kWS6du1qtm7darZu3Wr+/PNPY4wxv/76q70RzZkzx6xdu9a8/vrrxs3NzYwYMSLBCubLl8+0atXKLFu2zKxYscKcP3/e/Pbbb6Znz55mwYIFZtOmTWbFihWma9euxs3NzeGPd/v2bVOnTh3j4eFh+vfvb1atWmWWLVtmBg0aZObPn2+MMWbr1q3G19fXNGnSxF7rr7/+6lBD/DLPnj1rvLy8zODBgx22VfybxHPPPWcf9uWXXxqbzWZatGhhFi9ebJYvX26aNWtm3N3dUzR4fvXVV0aSmTJlSpKmj4yMNPny5TM5c+Y0U6dONatXr7aHrp49e9qnS27ofNR28bC1Xr582WzdutXkzp3bVK9e3b7ce0PM/RQvXtwEBAQkefp33nnHSDLPP/+8WblypZkzZ44pXLiwyZIli/n9999TdLtERESY119/3Xz77bcmIiLCfPfdd6ZFixbG19fX4eTqfqGzRIkSZtiwYSY8PNyMHz/eeHt7OxxwtmzZYmw2m2nXrp1ZtWqV2bBhg5k5c6Z56aWXkrQ93n77bSPJrFy50sTFxZmgoCBTqFChBCc0Sdkexhgzf/58I8n06dPHrF271qxbt85MnTrV9O3b1z5N1apVTcOGDe2/L1iwwPj4+BibzWb/QMkYY4KDg02bNm3svyd1v4zfdkFBQeatt94y4eHhCd5M7mf37t2ma9euRpJZvXq12bp1q/2E5pVXXjGSTO/evc3q1avN1KlTTc6cOU1gYKDDh1a1atUy2bNnN4GBgWbixIlm48aNJiIiItHXjD9mP/PMM2b58uVm7ty5pmjRoiYwMPChQ+eGDRuMl5eXqVmzplm4cKFZvXq16dSpU4LpunfvbjJkyGDGjx9vNm7caFasWGHeffddM3HiRGOMMX/++adp1aqV/cOde/fTe0NnUo9T8TUXLFjQNG7c2CxZssQsWbLElClTxmTLls3hzTd+2gd90JWYoKAg06RJE3P79u0EP9u2bUuwTTZt2mQ8PT1NxYoVzcKFC82SJUtMw4YNjc1mMwsWLLBP97Bt2Zm9e/eajBkzmoIFC5qpU6ea9evXm7lz55o2bdqYK1euGGNMkt8/k7NtnSlWrJjJkydPUjatXXLPDwoWLGheeOEFs3LlSjN//nxToEABU6xYMRMTE2OfNiX2+W+++cYMGzbMfPfddyYiIsIsWLDA1KpVy+TMmdO+z0ZGRtrfGyZNmmRv4/HB8N7Q+fHHHxtJDu8ZxhizatUqI8ksW7bMGHPnJLxx48bGz8/PjBw50oSHh5tp06aZfPnymVKlSpkbN248cLseP37cuLm5mdatWxtjjBkyZIiRZDZt2uQwXXJDZ1LaRlKPIYmFTi8vL1OgQAHz9ttvm7Vr15oRI0YYDw8P06xZs/vW6IpjcGKhM3/+/KZ06dJm/vz5ZtWqVaZKlSrG09PTDBs2zFSvXt0sXrzYfPfdd/Zzkbv/pklpe8YYs2/fPuPj42PKli1rFixYYJYtW2aaNGliChYsmCAsvP3228Zms5kuXbqYFStWmMWLF5uQkBDj5+dnP/9NzIkTJ0yePHmMv7+/GT9+vFm3bp1ZuHCh6dKlizl48KAxxvl7SVLPZcaOHWvc3d3N8OHDzfr1683q1avNhAkTHPb/Ro0amZw5c5rPP//cbNq0ySxZssQMGzbM4bh69/4WFRVltm7daipUqGAKFy5s3zcvX75sjEkYOpOyjpcuXTKdOnUyX375pdmwYYNZvXq16d+/v3FzczOzZ8+2Lys5GcMYY+bNm2ckmYYNG5olS5aYhQsXmooVKxovLy+zefNm+3RWnd/FxMSYF1980Xh6epr169ffty08SIqETknm66+/dpi2SZMmpkSJEvbfz5496/STA2PuNJb8+fPb/9jxevfubXx8fMyFCxeMMf/3x3j66acfWGtMTIy5ffu2qVevnsOng3PmzDGSzBdffHHf+f38/JyeiDhrEM8995zJnz+/w6ft8W8S8Z9cXb9+3WTPnt00b97cYXmxsbGmXLlypnLlyg9cp6R699137QfVpBgwYICRZLZv3+4wvGfPnsZms5lDhw4ZY5IfOh+1XTxKrcbc/yrEg/j4+JiqVasmadqLFy/aDyB3O3bsmPH29jbt27e3D7Niu8TExJhbt26ZYsWKmX79+tmH3y903n0VxZg7VyB8fHzsoXDcuHFG0gNPIp2Ji4szRYsWNfny5bOf6MW/7r0HrKRuj969e5usWbPe93WHDBlifH197aGlW7dupnHjxqZs2bL2AHvy5EkjyXz++efGmOTtl/HrMGzYsORsDgfxy7j7xODgwYNGkunVq5fDtNu3bzeSzKBBg+zDatWq5XQ7OhMbG2vy5s1rnnzySYewf/ToUePp6fnQobNkyZKmQoUKDlfcjDGmWbNmJk+ePPbjYOnSpU2LFi3uW+Orr76a4IQs3r2hM6n7fnzNZcqUcQgaP/30k5Fk/3Axflu4u7ubLl263LfOxDi7cpLYVS1j7oTJXLlymatXr9qHxcTEmNKlS5v8+fPb/04P05YTU7duXZM1a9ZkXQFL7P0zOdvWmcSOq7GxsQ6B/e730uSeH9x7HP7666/tH2wYY90+HxMTY65du2b8/PzMxx9/bB/+zTffON23jEkYOs+dO2e8vLwc9nljjGnTpo0JCAiw73PxH8ItWrTIYbr4q+uTJ09+YL2jRo1yOE/466+/jM1mS3DimdzQmZS2kdRjSGKhU5LDNjbm/z7o/N///nffOlPzGHz3690tKCjI+Pr6mhMnTtiH7d2710gyefLkcbhiu2TJEocPHJxJrO21bt3a+Pn5OaxrbGysKVWqlEPoPHbsmPHw8DB9+vRxWO7Vq1dN7ty5H/jBVpcuXYynp2eCO7vulthdM/euh7NzmWbNmjlcYXMmY8aM5rXXXrvvNPfub8b835Xre917/pWUdbxX/HG0a9eupkKFCg7jkpox4t/Hy5Qp43BcvHr1qsmVK5epVq2afZhV53cvvvii8fDwMN98802Spr+fFHlkis1mU/PmzR2GlS1bVn///fcD542KitL69ev17LPPKkOGDIqJibH/NGnSRFFRUdq2bZvDPC1btnS6rKlTp+rJJ5+Uj4+PPDw85OnpqfXr1+vgwYP2ab7//nv5+PioS5cuD7GmznXu3FknTpzQunXr7MNmzpyp3LlzKzQ0VJK0ZcsWXbhwQR07dnRYx7i4ODVu3Fg7duzQ9evXE32N2NjYBPOllA0bNqhUqVKqXLmyw/BOnTrJGKMNGzY81HIfpV2kdq2PYuvWrbp582aCnjYDAwNVt25drV+/3mH4o26XmJgYvfPOOypVqpS8vLzk4eEhLy8v/fHHHw5t/X7+85//JHj9qKgoRUZGSpKeeuopSVKbNm309ddfJ6un3oiICP3555/q2LGj3N3dJd3ZR2w2m2bMmJFg+qRsj8qVK+vSpUt6/vnntXTpUp07dy7BcurVq6ebN29qy5YtkqR169apQYMGql+/vsLDw+3DJKl+/fqSHm6/TOz487A2btwoSQnaT+XKlRUcHJyg/WTLlk1169Z94HIPHTqkf/75R+3bt3foPTEoKEjVqlV7qFr//PNP/fbbb/bvv9x7vD516pQOHTpkr//777/XgAEDtGnTpkf+Dnly9/2mTZva2590p01JcmhXQUFBiomJ0fTp0x+6rho1amjHjh0JfubMmeMw3fXr17V9+3a1atVKGTNmtA93d3fXSy+9pBMnTti33cO0ZWdu3LihiIgItWnTRjlz5rzveiTl/TNeUrZtcjz33HPy9PS0//Tt21fSw50fODu23V1bSu3z165d01tvvaWiRYvKw8NDHh4eypgxo65fv57k4/C9cuTIoebNm2v27Nn29/iLFy9q6dKl6tChg73vihUrVihr1qxq3ry5wzqUL19euXPnfmDPl8YYzZw5U4GBgWrQoIEkqVChQqpdu7YWLVqkK1euPFT90oPbRnKOIfdz73fw2rdvL+n/jqfJYdUx+H7Kly/v0GlTcHCwpDvfnbv7+6Hxw+/et5La9iIiIlS3bl35+/vbh7m5ualNmzYOtaxZs0YxMTHq0KGDw9/Dx8dHtWrVemB7+v7771WnTh17rUmV1HOZypUra9++ferVq5fWrFnjtH1WrlxZs2bN0pgxY7Rt2zbdvn07WbU8SFLX8ZtvvlH16tWVMWNG+3F0+vTpD31MiH8ff+mll+Tm9n+RLWPGjGrZsqW2bdumGzduOMyTkud3a9eu1dy5c/Xhhx+mSGeQKRI6M2TIIB8fH4dh3t7eioqKeuC858+fV0xMjCZOnOjwpuPp6akmTZpIUoITTGe9kI4fP149e/ZUlSpVtGjRIm3btk07duxQ48aNHU52zp49q7x58zr88R5VaGio8uTJo5kzZ0q68yaxbNkydejQwX7wje/Fs1WrVgnW87333pMxRhcuXEj0NYoUKeIwz6hRoxKdtkCBApLudIaTFOfPn3e6TfPmzWsf/zAepV0kxqpa71WgQIFkbT/JebvMmzdvgpoedbuEhYVp6NChatGihZYvX67t27drx44dKleuXJJP7HPkyJHg9SXZ53/66ae1ZMkS+xtR/vz5Vbp0ac2fP/+By44/gX/22Wd16dIlXbp0SVmyZFGNGjW0aNEiXbp0yWH6pGyPl156STNmzNDff/+tli1bKleuXKpSpYr9BFySqlWrpgwZMmjdunX6888/dfToUfuJ+vbt23Xt2jWtW7dOhQsXVqFChSQ93H6Z3F6QHyS57Seprx8/X+7cuROMczYsKeK3V//+/RNsr169ekn6v+P1J598orfeektLlixRnTp1lD17drVo0UJ//PHHQ712cvf9B7XxlJIlSxZVqlQpwc+9JycXL16UMSZJ6/AwbdmZixcvKjY29oEdmST1/TPew27bAgUKOA2mH374oT2s3+1hzg8eVFtK7fPt27fXp59+qm7dumnNmjX66aeftGPHDuXMmfOR2liXLl108uRJ+7Ft/vz5io6OdghEZ86c0aVLl+Tl5ZVgHU6fPu30Q7m7bdiwQUeOHFHr1q115coV+3G6TZs2unHjRpKO84lJ6vZPyjEkMR4eHgleJ/6Y9jDnAFYdg+8nvpfUeF5eXvcdfvf7YVLb3vnz5xUQEJDgte8dFv83eeqppxL8TRYuXPjAv8fZs2cfqrOkpJ7LDBw4UOPGjdO2bdsUGhqqHDlyqF69eg6Pb1y4cKE6duyoadOmKSQkRNmzZ1eHDh10+vTpZNf1sOu4ePFitWnTRvny5dPcuXO1detW7dixQ126dHno894Htc24uDhdvHjRYXhKnt8dOHBA0p0Pk1KCy3uvzZYtm/2T3ldffdXpNPe+qTp75tHcuXNVu3ZtTZkyxWH41atXHX7PmTOn/ve//ykuLi7Fgmd8/Z988okuXbqkr776StHR0ercubN9mvhPmiZOnJhoz1TODg7xli9f7vB8nPiTFGfq1KkjT09PLVmyRD169Hhg/Tly5NCpU6cSDP/nn38cao8PBnfXIT34DSIlJbXWR9WoUSNNnDhR27Zte2BPYvE7eGJ1pVRN8ebOnasOHTronXfecRh+7ty5FH3m2DPPPKNnnnlG0dHR2rZtm8aOHav27durYMGCCgkJcTrP5cuXtWjRIkn/92navb766iv7yUVydO7cWZ07d9b169f1ww8/aPjw4WrWrJl+//13BQUFycvLSzVq1NC6deuUP39+5c6dW2XKlFHhwoUl3Xmm1Pr16x2eR/cw+2VKP3Pt7vZz75uas/aT1NePX66zN917hyV1346vZeDAgXruueecvm6JEiUkSX5+fho5cqRGjhypM2fO2K96Nm/eXL/99luS1uHe9UmNfd8q2bJlk5ubW5LW4WHasjPZs2eXu7u7Tpw4cd/pkvr++agaNGigSZMmaefOnapUqZJ9eGK9uD7M+cGDpMQ+f/nyZa1YsULDhw/XgAED7MOjo6Pv++FxUjRq1Eh58+bVzJkz1ahRI82cOVNVqlRxeISCv7+/cuTIodWrVztdRqZMme77GvEfDI4fP17jx493Or579+6PsBaJS84xJDExMTE6f/68w8l1/DHt3hPupLDqGGyF5LS9HDly2APl3e49/sev37fffqugoKBk15QzZ84HHmOcSeq5jIeHh8LCwhQWFqZLly5p3bp1GjRokBo1aqTjx48rQ4YM8vf314QJEzRhwgQdO3ZMy5Yt04ABAxQZGZnofpIcSVnHuXPnqlChQlq4cKFDG7n3fTU5HnR+6ebm9lC9fSf1/C5LliwqUaJEggsDDyvlLvc9QGKfhGbIkEF16tTRnj17VLZsWaefGCflIGKz2RI8b+nnn3/W1q1bHYaFhoYqKirqgQ+o9fb2TtanlZ07d1ZUVJTmz5+vWbNmKSQkRCVLlrSPr169urJmzaoDBw44XcdKlSrZP9FypkyZMg7T3i905s6d2/4J2L23eMU7fPiwfv75Z0l3buU6cOCAdu/e7TDNnDlzZLPZVKdOHUmyP2Msfr54y5YtS3zDPEByrz4ktdZH1a9fP/n5+alXr166fPlygvHGGPsjU0JCQuTr62t/3lm8EydOaMOGDQ/1vLn7bRdnbX3lypXJugU2ubXUqlVL7733niTd99mkX331lW7evKnRo0dr48aNCX78/f2d3mKbHH5+fgoNDdXgwYN169Yt/frrr/Zx9evX165du7Ro0SL7bYd+fn6qWrWqJk6cqH/++cfhdsRH3S9TQvxtWve2nx07dujgwYMP/bzCEiVKKE+ePJo/f76MMfbhf//9t/22zXhJ3bdLlCihYsWKad++fYluL2cnvAEBAerUqZOef/55HTp0yH47UHL2/9Ta963i5+enKlWqaPHixQ7rGxcXp7lz5yp//vwqXry4fXhy27Izvr6+qlWrlr755pv7fjiY1PfPR9WvXz9lyJBBr776apICbUqdH9wtJfZ5m80mY0yCbTZt2jTFxsY6DEvue1x8yF6yZIk2b96snTt3Jvg6ULNmzXT+/HnFxsY6rf9+oe3ixYv67rvvVL16dafH6BdeeEE7duywP1okpT3sMeRe8+bNc/j9q6++kvRwz7W26hhsheS0vVq1amnDhg0O+35cXJy++eYbh+kaNWokDw8PHT58ONG/yf2EhoZq48aNSbot+t51Se65TNasWdWqVSu9+uqrunDhgo4ePZpgmgIFCqh3795q0KBBgveLh5WUdbTZbPLy8nIInKdPn9bSpUsTTJvUjFGiRAnly5dPX331lcP7+PXr17Vo0SKFhIQ80iOcHnR+17lzZ/32228p9vzeVLvSmSlTJgUFBWnp0qWqV6+esmfPLn9/fxUsWFAff/yxatSooZo1a6pnz54qWLCgrl69qj///FPLly9P0vf0mjVrptGjR2v48OGqVauWDh06pFGjRqlQoUKKiYmxT/f8889r5syZ6tGjhw4dOqQ6deooLi5O27dvV3BwsNq1ayfpTsjbtGmTli9frjx58ihTpkz3PZCXLFlSISEhGjt2rI4fP67PP//cYXzGjBk1ceJEdezYURcuXFCrVq2UK1cunT17Vvv27dPZs2cTfMr8KMaPH6+//vpLnTp10po1a/Tss88qICBA586dU3h4uGbOnKkFCxaobNmy6tevn+bMmaOmTZtq1KhRCgoK0sqVKzV58mT17NnTfiKUO3du1a9fX2PHjlW2bNkUFBSk9evXa/HixQ9d5/3ahTNJrfVRFSpUSAsWLFDbtm1Vvnx59e7d2/7cwAMHDmjGjBkyxujZZ59V1qxZNXToUA0aNEgdOnTQ888/r/Pnz2vkyJHy8fHR8OHDk/3699suzZo106xZs1SyZEmVLVtWu3bt0gcffJCizwIbNmyYTpw4oXr16il//vy6dOmSPv74Y3l6eqpWrVqJzjd9+nRly5ZN/fv3d/rJWIcOHTR+/Hjt27dP5cqVS3I9L7/8snx9fVW9enXlyZNHp0+f1tixY5UlSxaHK6r16tVTbGys1q9fr9mzZ9uH169fX8OHD5fNZnP4Lk5q75fOlChRQq+88oomTpwoNzc3hYaG6ujRoxo6dKgCAwPVr1+/h1qum5ubRo8erW7duunZZ5/Vyy+/rEuXLmnEiBEJbq9Nzr792WefKTQ0VI0aNVKnTp2UL18+XbhwQQcPHtTu3bvtJzRVqlRRs2bNVLZsWWXLlk0HDx7Ul19+6fAmWaZMGUnSe++9p9DQULm7u6ts2bJOT/qt2Pf//vtvFSlSRB07dnyk73Um1dixY9WgQQPVqVNH/fv3l5eXlyZPnqz9+/dr/vz5DicryW3LiRk/frxq1KihKlWqaMCAASpatKjOnDmjZcuW6bPPPlOmTJmS/P75qIoUKaL58+fr+eefV5kyZdSzZ089+eST8vb2VmRkpNauXStJDs/vTInzg7ulxD6fOXNmPf300/rggw/sx+WIiAhNnz49wd0mpUuXliR9/vnnypQpk3x8fFSoUKH7huUuXbrovffeU/v27eXr66u2bds6jG/Xrp3mzZunJk2a6L///a8qV64sT09PnThxQhs3btQzzzyjZ5991umy582bp6ioKPXt29dpQMuRI4fmzZun6dOn66OPPrrvdnhYST2GJMbLy0sffvihrl27pqeeekpbtmzRmDFjFBoaqho1aiS7HquOwVZITtsbPHiwli9frnr16mnw4MHy9fXV1KlT7d9Zjr/br2DBgho1apQGDx6sv/76S40bN1a2bNl05swZ/fTTT/a7VhIzatQoff/993r66ac1aNAglSlTRpcuXdLq1asVFhbmcAHmbkk9l2nevLlKly6tSpUqKWfOnPr77781YcIEBQUFqVixYrp8+bLq1Kmj9u3bq2TJksqUKZN27Nih1atXJ3o1PbmSso7NmjXT4sWL1atXL7Vq1UrHjx/X6NGjlSdPngRfK0lqxnBzc9P777+vF154Qc2aNVP37t0VHR2tDz74QJcuXdK7776b7HVJzvndqFGjNGrUKB0+fPihroInkJxeh+73nM57Oeuxa926daZChQrG29s7QTf1R44cMV26dDH58uUznp6eJmfOnKZatWpmzJgx9mnie3Vy1oNSdHS06d+/v8mXL5/x8fExTz75pFmyZInT3qpu3rxphg0bZooVK2a8vLxMjhw5TN26dR2eebN3715TvXp1kyFDBiM9+Bk6xhjz+eefG0nG19c3QU978SIiIkzTpk1N9uzZjaenp8mXL59p2rRpivQKda+YmBgze/ZsU7duXZM9e3bj4eFhcubMaUJDQ81XX33l0BPW33//bdq3b29y5MhhPD09TYkSJcwHH3zgMI0xd54B2qpVK5M9e3aTJUsW8+KLL5qdO3c67b02JdqFM0mt9VF6r413+PBh06tXL1O0aFHj7e1tfH19TalSpUxYWFiCZxNNmzbNlC1b1nh5eZksWbKYZ555JkFX4ymxXS5evGi6du1qcuXKZTJkyGBq1KhhNm/ebGrVqmVvp8bcv/fau3uzM+b/9u34dVqxYoUJDQ01+fLlM15eXiZXrlymSZMmDt1z32vfvn1G0n17kPvtt9+M/v+jT5KzPWbPnm3q1KljAgICjJeXl8mbN69p06ZNgud5xcXFGX9/fyPJnDx50j78xx9/NJLMk08+6bSupOyXiW275EhsGfHPiCtevLjx9PQ0/v7+5sUXX0z0GXHJMW3aNPuxrnjx4mbGjBlOj4tJ3beNufO3btOmjcmVK5fx9PQ0uXPnNnXr1jVTp061TzNgwABTqVIl+3P4ChcubPr162fOnTtnnyY6Otp069bN5MyZ09hsNoc2mNhzOh+079+vt03d0yNhSjwy5WGf0+nn52d8fX1N1apV7b2c3+1h27IzBw4cMK1btzY5cuSwP26iU6dO9t5xk/r+mZxtez+HDx82ffr0MSVKlDC+vr7G29vbBAUFmdatW5vvvvvO6bMiH/b8ILFeMx91nz9x4oRp2bKlyZYtm8mUKZNp3Lix2b9/v9N2O2HCBFOoUCHj7u7uUIuz/TBetWrVjCTzwgsvOB1/+/ZtM27cOFOuXDnj4+NjMmbMaEqWLGm6d+/u9Lnh8cqXL29y5cploqOjE52matWqxt/f30RHRz/Uczrv5axtJOUYcr/ndP7888+mdu3axtfX12TPnt307NnTXLt27b41GpP6x+D7PafzXpLMq6++6jDM2XZNTtvbvHmzqVKlivH29ja5c+c2b7zxhnnvvfec9l66ZMkSU6dOHZM5c2b7PtmqVaskPdLv+PHjpkuXLiZ37tzG09PT/h595swZh/W4ez9M6rnMhx9+aKpVq2b8/f3tx6+uXbvan0saFRVlevToYcqWLWt/7mSJEiXM8OHDHXoCfpTea5OyjsbceXpE/LOpg4ODzRdffOG0DSQ3YyxZssRUqVLF+Pj4GD8/P1OvXj2Hx2cZY835Xfwyk/MszvuxGXPX9VoAQLrXqVMnbdq0yemtSQDwuOrUqZO+/fZbXbt2zdWlpFkNGzbU0aNH9fvvv7u6FPzLuLwjIQAAAAApKywsTBUqVFBgYKAuXLigefPmKTw8PFW+TgDci9AJAAAApDOxsbEaNmyYTp8+LZvNplKlSunLL7/Uiy++6OrS8C/E7bUAAAAAAMuk2iNTAAAAAAD/PoROAAAAAIBlCJ0AAAAAAMvQkRDSrbi4OP3zzz/KlCmTw0PXAQAAHjfGGF29elV58+aVmxvXhZC+EDqRbv3zzz8KDAx0dRkAAABJdvz4ceXPn9/VZQApitCJdCtTpkyS7hy8M2fO7OJqAAAAEnflyhUFBgbaz1+A9ITQiXQr/pbazJkzEzoBAECawFeCkB5xwzgAAAAAwDKETgAAAACAZQidAAAAAADLEDoBAAAAAJYhdAIAAAAALEPoBAAAAABYhtAJAAAAALAMoRMAAAAAYBlCJwAAAADAMoROWO6HH35Q8+bNlTdvXtlsNi1ZsuSB80RERKhixYry8fFR4cKFNXXqVOsLBQAAAJDiCJ2w3PXr11WuXDl9+umnSZr+yJEjatKkiWrWrKk9e/Zo0KBB6tu3rxYtWmRxpQAAAABSmoerC0D6FxoaqtDQ0CRPP3XqVBUoUEATJkyQJAUHB2vnzp0aN26cWrZsaVGVAAAAAKzAlU48drZu3aqGDRs6DGvUqJF27typ27dvu6gqAAAAAA+DK5147Jw+fVoBAQEOwwICAhQTE6Nz584pT548TueLjo5WdHS0/fcrV65YWicAAACAByN04rFks9kcfjfGOB1+t7Fjx2rkyJGW1uVMwQErU/018XCOvts01V6LdpF2pFa7oE2kHRwr4ExqtgsgveH2Wjx2cufOrdOnTzsMi4yMlIeHh3LkyJHofAMHDtTly5ftP8ePH7e6VAAAAAAPwJVOPHZCQkK0fPlyh2Fr165VpUqV5Onpmeh83t7e8vb2tro8AAAAAMnAlU5Y7tq1a9q7d6/27t0r6c4jUfbu3atjx45JunOFskOHDvbpe/Toob///lthYWE6ePCgZsyYoenTp6t///6uKB8AAADAI+BKJyy3c+dO1alTx/57WFiYJKljx46aNWuWTp06ZQ+gklSoUCGtWrVK/fr106RJk5Q3b1598sknPC4FAAAASIMInbBc7dq17R0BOTNr1qwEw2rVqqXdu3dbWBUAAACA1MDttQAAAAAAyxA6AQAAAACWIXQCAAAAACxD6AQAAAAAWIbQCQAAAACwDKETAAAAAGAZQicAAAAAwDKETgAAAACAZQidAAAAAADLEDoBAAAAAJYhdAIAAAAALEPoBAAAAABYhtAJAAAAALAMoRMAAAAAYBlCJwAAAADAMoROAAAAAIBlCJ0AAAAAAMsQOgEAAAAAliF0AgAAAAAsQ+gEAAAAAFiG0AkAAAAAsAyhEwAAAABgGUInAAAAAMAyhE4AAAAAgGUInQAAAAAAyxA6AQAAAACWIXQCAAAAACxD6AQAAAAAWIbQCQAAAACwDKETAAAAAGAZQicAAAAAwDKETgAAAACAZQidAAAAAADLEDoBAAAAAJYhdAIAAAAALEPoBAAAAABYhtAJAAAAALAMoRMAAAAAYBlCJwAAAADAMoROAAAAAIBlCJ0AAAAAAMsQOgEAAAAAliF0AgAAAAAsQ+gEAAAAAFiG0AkAAAAAsAyhEwAAAABgGUInAAAAAMAyhE4AAAAAgGUInQAAAAAAyxA6AQAAAACWIXQCAAAAACxD6AQAAAAAWIbQCQAAAACwDKETAAAAAGAZQicAAAAAwDKETqSayZMnq1ChQvLx8VHFihW1efPm+04/b948lStXThkyZFCePHnUuXNnnT9/PpWqBQAAAJASCJ1IFQsXLtRrr72mwYMHa8+ePapZs6ZCQ0N17Ngxp9P/73//U4cOHdS1a1f9+uuv+uabb7Rjxw5169YtlSsHAAAA8CgInUgV48ePV9euXdWtWzcFBwdrwoQJCgwM1JQpU5xOv23bNhUsWFB9+/ZVoUKFVKNGDXXv3l07d+5M5coBAAAAPApCJyx369Yt7dq1Sw0bNnQY3rBhQ23ZssXpPNWqVdOJEye0atUqGWN05swZffvtt2ratGmirxMdHa0rV644/AAAAABwLUInLHfu3DnFxsYqICDAYXhAQIBOnz7tdJ5q1app3rx5atu2rby8vJQ7d25lzZpVEydOTPR1xo4dqyxZsth/AgMDU3Q9AAAAACQfoROpxmazOfxujEkwLN6BAwfUt29fDRs2TLt27dLq1at15MgR9ejRI9HlDxw4UJcvX7b/HD9+PEXrBwAAAJB8Hq4uAOmfv7+/3N3dE1zVjIyMTHD1M97YsWNVvXp1vfHGG5KksmXLys/PTzVr1tSYMWOUJ0+eBPN4e3vL29s75VcAAAAAwEPjSics5+XlpYoVKyo8PNxheHh4uKpVq+Z0nhs3bsjNzbF5uru7S7pzhRQAAABA2kDoRKoICwvTtGnTNGPGDB08eFD9+vXTsWPH7LfLDhw4UB06dLBP37x5cy1evFhTpkzRX3/9pR9//FF9+/ZV5cqVlTdvXletBgAAAIBk4vZapIq2bdvq/PnzGjVqlE6dOqXSpUtr1apVCgoKkiSdOnXK4ZmdnTp10tWrV/Xpp5/q9ddfV9asWVW3bl299957rloFAAAAAA+B0IlU06tXL/Xq1cvpuFmzZiUY1qdPH/Xp08fiqgAAAABYidtrAQAAAACWIXQCAAAAACxD6AQAAAAAWIbQCQAAAACwDKETAAAAAGAZQicAAAAAwDKETgAAAACAZQidAAAAAADLEDoBAAAAAJYhdAIAAAAALEPoBAAAAABYhtAJAAAAALAMoRMAAAAAYBlCJwAAAADAMoROAAAAAIBlCJ0AAAAAAMsQOgEAAAAAliF0AgAAAAAsQ+gEAAAAAFiG0AkAAAAAsAyhEwAAAABgGUInAAAAAMAyhE4AAAAAgGUInQAAAAAAyxA6AQAAAACWIXQCAAAAACxD6AQAAAAAWIbQCQAAAACwDKETSXLlyhUtWbJEBw8edHUpAAAAANIQQiecatOmjT799FNJ0s2bN1WpUiW1adNGZcuW1aJFi1xcHQAAAIC0gtAJp3744QfVrFlTkvTdd9/JGKNLly7pk08+0ZgxY1xcHQAAAIC0gtAJpy5fvqzs2bNLklavXq2WLVsqQ4YMatq0qf744w8XVwcAAAAgrSB0wqnAwEBt3bpV169f1+rVq9WwYUNJ0sWLF+Xj4+Pi6gAAAACkFR6uLgCPp9dee00vvPCCMmbMqKCgINWuXVvSndtuy5Qp49riAAAAAKQZhE441atXL1WuXFnHjx9XgwYN5OZ256J44cKF+U4nAAAAgCQjdCJRlSpVUqVKlRyGNW3a1EXVAAAAAEiL+E4nnGrVqpXefffdBMM/+OADtW7d2gUVAQAAAEiLCJ1wKiIiwulVzcaNG+uHH35wQUUAAAAA0iJCJ5y6du2avLy8Egz39PTUlStXXFARAAAAgLSI0AmnSpcurYULFyYYvmDBApUqVcoFFQEAAABIi+hICE4NHTpULVu21OHDh1W3bl1J0vr16zV//nx98803Lq4OAAAAQFpB6IRT//nPf7RkyRK98847+vbbb+Xr66uyZctq3bp1qlWrlqvLAwAAAJBGEDqRqKZNm/KIFAAAAACPhNCJ+9q1a5cOHjwom82mUqVKqUKFCq4uCQAAAEAaQuiEU5GRkWrXrp02bdqkrFmzyhijy5cvq06dOlqwYIFy5szp6hIBAAAApAH0Xgun+vTpoytXrujXX3/VhQsXdPHiRe3fv19XrlxR3759XV0eAAAAgDSCK51wavXq1Vq3bp2Cg4Ptw0qVKqVJkyapYcOGLqwMAAAAQFrClU44FRcXJ09PzwTDPT09FRcX54KKAAAAAKRFhE44VbduXf33v//VP//8Yx928uRJ9evXT/Xq1XNhZQAAAADSEkInnPr000919epVFSxYUEWKFFHRokVVqFAhXb16VRMnTnR1eQAAAADSCL7TCacCAwO1e/duhYeH67fffpMxRqVKlVL9+vVdXRoAAACANITQiftq0KCBGjRo4OoyAAAAAKRRhE4kEBcXp1mzZmnx4sU6evSobDabChUqpFatWumll16SzWZzdYkAAAAA0gi+0wkHxhj95z//Ubdu3XTy5EmVKVNGTzzxhP7++2916tRJzz77rKtLBAAAAJCGcKUTDmbNmqUffvhB69evV506dRzGbdiwQS1atNCcOXPUoUMHF1UIAAAAIC3hSicczJ8/X4MGDUoQOKU7j1EZMGCA5s2b91DLnjx5sgoVKiQfHx9VrFhRmzdvvu/00dHRGjx4sIKCguTt7a0iRYpoxowZD/XaAAAAAFyD0AkHP//8sxo3bpzo+NDQUO3bty/Zy124cKFee+01DR48WHv27FHNmjUVGhqqY8eOJTpPmzZttH79ek2fPl2HDh3S/PnzVbJkyWS/NgAAAADX4fZaOLhw4YICAgISHR8QEKCLFy8me7njx49X165d1a1bN0nShAkTtGbNGk2ZMkVjx45NMP3q1asVERGhv/76S9mzZ5ckFSxYMNmvCwAAAMC1uNIJB7GxsfLwSPyzCHd3d8XExCRrmbdu3dKuXbvUsGFDh+ENGzbUli1bnM6zbNkyVapUSe+//77y5cun4sWLq3///rp582airxMdHa0rV644/AAAAABwLa50woExRp06dZK3t7fT8dHR0cle5rlz5xQbG5vgCmpAQIBOnz7tdJ6//vpL//vf/+Tj46PvvvtO586dU69evXThwoVEv9c5duxYjRw5Mtn1AQAAALAOoRMOOnbs+MBpHrbn2nuf72mMSfSZn3FxcbLZbJo3b56yZMki6c4tuq1atdKkSZPk6+ubYJ6BAwcqLCzM/vuVK1cUGBj4ULUCAAAASBmETjiYOXNmii/T399f7u7uCa5qRkZGJvr90Tx58ihfvnz2wClJwcHBMsboxIkTKlasWIJ5vL29E71CCwAAAMA1+E4nLOfl5aWKFSsqPDzcYXh4eLiqVavmdJ7q1avrn3/+0bVr1+zDfv/9d7m5uSl//vyW1gsAAAAg5RA6kSrCwsI0bdo0zZgxQwcPHlS/fv107Ngx9ejRQ9KdW2Pvvm23ffv2ypEjhzp37qwDBw7ohx9+0BtvvKEuXbo4vbUWAAAAwOOJ22uRKtq2bavz589r1KhROnXqlEqXLq1Vq1YpKChIknTq1CmHZ3ZmzJhR4eHh6tOnjypVqqQcOXKoTZs2GjNmjKtWAQAAAMBDIHQi1fTq1Uu9evVyOm7WrFkJhpUsWTLBLbkAAAAA0hZurwUAAAAAWIYrnUjU77//rk2bNikyMlJxcXEO44YNG+aiqgAAAACkJYROOPXFF1+oZ8+e8vf3V+7cuR2ep2mz2QidAAAAAJKE0AmnxowZo7fffltvvfWWq0sBAAAAkIbxnU44dfHiRbVu3drVZQAAAABI4widcKp169Zau3atq8sAAAAAkMZxey2cKlq0qIYOHapt27apTJky8vT0dBjft29fF1UGAAAAIC0hdMKpzz//XBkzZlRERIQiIiIcxtlsNkInAAAAgCQhdMKpI0eOuLoEAAAAAOkA3+kEAAAAAFiGK51wEBYWlqTpxo8fb3ElAAAAANIDQicc7Nmz54HT2Gy2VKgEAAAAQHpA6ISDjRs3uroEAAAAAOkI3+kEAAAAAFiG0AkAAAAAsAyhEwAAAABgGUInAAAAAMAyhE4AAAAAgGXovRZ2P//8c5KnLVu2rIWVAAAAAEgvCJ2wK1++vGw2m4wxD3wWZ2xsbCpVBQAAACAt4/Za2B05ckR//fWXjhw5okWLFqlQoUKaPHmy9uzZoz179mjy5MkqUqSIFi1a5OpSAQAAAKQRXOmEXVBQkP3/rVu31ieffKImTZrYh5UtW1aBgYEaOnSoWrRo4YIKAQAAAKQ1XOmEU7/88osKFSqUYHihQoV04MABF1QEAAAAIC0idMKp4OBgjRkzRlFRUfZh0dHRGjNmjIKDg11YGQAAAIC0hNtr4dTUqVPVvHlzBQYGqly5cpKkffv2yWazacWKFS6uDgAAAEBaQeiEU5UrV9aRI0c0d+5c/fbbbzLGqG3btmrfvr38/PxcXR4AAACANILQiURlyJBBr7zyiqvLAAAAAJCGETqRqN9//12bNm1SZGSk4uLiHMYNGzbMRVUBAAAASEsInXDqiy++UM+ePeXv76/cuXPLZrPZx9lsNkInAAAAgCQhdMKpMWPG6O2339Zbb73l6lIAAAAApGE8MgVOXbx4Ua1bt3Z1GQAAAADSOEInnGrdurXWrl3r6jIAAAAApHHcXgunihYtqqFDh2rbtm0qU6aMPD09Hcb37dvXRZUBAAAASEsInXDq888/V8aMGRUREaGIiAiHcTabjdAJAAAAIEkInXDqyJEjri4BAAAAQDrAdzoBAAAAAJbhSiec6tKly33Hz5gxI5UqAQAAAJCWETrh1MWLFx1+v337tvbv369Lly6pbt26LqoKAAAAQFpD6IRT3333XYJhcXFx6tWrlwoXLuyCigAAAACkRXynE0nm5uamfv366aOPPnJ1KQAAAADSCEInkuXw4cOKiYlxdRkAAAAA0ghur4VTYWFhDr8bY3Tq1CmtXLlSHTt2dFFVAAAAANIaQiec2rNnj8Pvbm5uypkzpz788MMH9mwLAAAAAPEInXBq48aNri4BAAAAQDpA6MR9nT17VocOHZLNZlPx4sWVM2dOV5cEAAAAIA2hIyE4df36dXXp0kV58uTR008/rZo1aypv3rzq2rWrbty44eryAAAAAKQRhE44FRYWpoiICC1fvlyXLl3SpUuXtHTpUkVEROj11193dXkAAAAA0ghur4VTixYt0rfffqvatWvbhzVp0kS+vr5q06aNpkyZ4rriAAAAAKQZXOmEUzdu3FBAQECC4bly5eL2WgAAAABJRuiEUyEhIRo+fLiioqLsw27evKmRI0cqJCTEhZUBAAAASEu4vRZOffzxx2rcuLHy58+vcuXKyWazae/evfLx8dGaNWtcXR4AAACANILQCadKly6tP/74Q3PnztVvv/0mY4zatWunF154Qb6+vq4uDwAAAEAaQeiEgw0bNujpp5+Wh4eHfH199fLLL7u6JAAAAABpGN/phIMGDRrowoUL9t+rVq2qkydPurAiAAAAAGkZoRMOjDEOv//666+Kjo5OkWVPnjxZhQoVko+PjypWrKjNmzcnab4ff/xRHh4eKl++fIrUAQAAACD1EDqRKhYuXKjXXntNgwcP1p49e1SzZk2Fhobq2LFj953v8uXL6tChg+rVq5dKlQIAAABISYROOLDZbLLZbIn+/rDGjx+vrl27qlu3bgoODtaECRMUGBioKVOm3He+7t27q3379jymBQAAAEij6EgIDowxqlevnjw87jSNGzduqHnz5vLy8nKYbvfu3Ule5q1bt7Rr1y4NGDDAYXjDhg21ZcuWROebOXOmDh8+rLlz52rMmDHJWAsAAAAAjwtCJxwMHz7c4fdnnnnmkZd57tw5xcbGKiAgwGF4QECATp8+7XSeP/74QwMGDNDmzZvtAfhBoqOjHb5/euXKlYcvGgAAAECKIHTCwb2hMyXde5uuMcbprbuxsbFq3769Ro4cqeLFiyd5+WPHjtXIkSMfuU4AAAAAKYfvdMJy/v7+cnd3T3BVMzIyMsHVT0m6evWqdu7cqd69e8vDw0MeHh4aNWqU9u3bJw8PD23YsMHp6wwcOFCXL1+2/xw/ftyS9QEAAACQdFzphOW8vLxUsWJFhYeH69lnn7UPDw8Pd3r7bubMmfXLL784DJs8ebI2bNigb7/9VoUKFXL6Ot7e3vL29k7Z4gEAAAA8EkInUkVYWJheeuklVapUSSEhIfr888917Ngx9ejRQ9Kdq5QnT57UnDlz5ObmptKlSzvMnytXLvn4+CQYDgAAAODxRuhEqmjbtq3Onz+vUaNG6dSpUypdurRWrVqloKAgSdKpU6ce+MxOAAAAAGkPoROpplevXurVq5fTcbNmzbrvvCNGjNCIESNSvigAAAAAlqIjISSqd+/eunDhgqvLAAAAAJCGETrh4MSJE/b/f/XVV7p27ZokqUyZMvQGCwAAACDZuL0WDkqWLKkcOXKoevXqioqK0vHjx1WgQAEdPXpUt2/fdnV5AAAAANIYrnTCweXLl/XNN9+oYsWKiouLU5MmTVS8eHFFR0drzZo1CZ61CQAAAAD3Q+iEg9u3b6ty5cp6/fXX5evrqz179mjmzJlyd3fXjBkzVKRIEZUoUcLVZQIAAABII7i9Fg4yZ86sChUqqHr16rp165Zu3Lih6tWry8PDQwsXLlT+/Pn1008/ubpMAAAAAGkEVzrh4J9//tGQIUPk7e2tmJgYVapUSTVr1tStW7e0e/du2Ww21ahRw9VlAgAAAEgjCJ1w4O/vr+bNm2vs2LHKkCGDduzYoT59+shms6l///7KnDmzatWq5eoyAQAAAKQRhE7cV5YsWdSmTRt5enpqw4YNOnLkiHr16uXqsgAAAACkEXynE4n6+eeflS9fPklSUFCQPD09lTt3brVt29bFlQEAAABIKwidSFRgYKD9//v373dhJQAAAADSKm6vBQAAAABYhtAJAAAAALAMoRMAAAAAYBlCJwAAAADAMoROAAAAAIBlCJ0AAAAAAMsQOgEAAAAAliF0AgAAAAAsQ+gEAAAAAFiG0AkAAAAAsAyhEwAAAABgGUInAAAAAMAyhE4AAAAAgGUInQAAAAAAyxA6AQAAAACWIXQCAAAAACxD6AQAAAAAWIbQCQAAAACwDKETAAAAAGAZQicAAAAAwDKETgAAAACAZQidAAAAAADLEDoBAAAAAJYhdAIAAAAALEPoBAAAAABYhtAJAAAAALAMoRMAAAAAYBlCJwAAAADAMoROAAAAAIBlCJ0AAAAAAMsQOgEAAAAAliF0AgAAAAAsQ+gEAAAAAFiG0AkAAAAAsAyhEwAAAABgGUInAAAAAMAyhE4AAAAAgGUInQAAAAAAyxA6AQAAAACWIXQCAAAAACxD6AQAAAAAWIbQCQAAAACwDKETAAAAAGAZQicAAAAAwDKETqSayZMnq1ChQvLx8VHFihW1efPmRKddvHixGjRooJw5cypz5swKCQnRmjVrUrFaAAAAACmB0IlUsXDhQr322msaPHiw9uzZo5o1ayo0NFTHjh1zOv0PP/ygBg0aaNWqVdq1a5fq1Kmj5s2ba8+ePalcOQAAAIBHQehEqhg/fry6du2qbt26KTg4WBMmTFBgYKCmTJnidPoJEybozTff1FNPPaVixYrpnXfeUbFixbR8+fJUrhwAAADAoyB0wnK3bt3Srl271LBhQ4fhDRs21JYtW5K0jLi4OF29elXZs2dPdJro6GhduXLF4QcAAACAaxE6Yblz584pNjZWAQEBDsMDAgJ0+vTpJC3jww8/1PXr19WmTZtEpxk7dqyyZMli/wkMDHykugEAAAA8OkInUo3NZnP43RiTYJgz8+fP14gRI7Rw4ULlypUr0ekGDhyoy5cv23+OHz/+yDUDAAAAeDQeri4A6Z+/v7/c3d0TXNWMjIxMcPXzXgsXLlTXrl31zTffqH79+ved1tvbW97e3o9cLwAAAICUw5VOWM7Ly0sVK1ZUeHi4w/Dw8HBVq1Yt0fnmz5+vTp066auvvlLTpk2tLhMAAACABbjSiVQRFhaml156SZUqVVJISIg+//xzHTt2TD169JB059bYkydPas6cOZLuBM4OHTro448/VtWqVe1XSX19fZUlSxaXrQcAAACA5CF0IlW0bdtW58+f16hRo3Tq1CmVLl1aq1atUlBQkCTp1KlTDs/s/OyzzxQTE6NXX31Vr776qn14x44dNWvWrNQuHwAAAMBDInQi1fTq1Uu9evVyOu7eILlp0ybrCwIAAABgOb7TCQAAAACwDKETAAAAAGAZQicAAAAAwDKETgAAAACAZQidAAAAAADLEDoBAAAAAJYhdAIAAAAALEPoBAAAAABYhtAJAAAAALAMoRMAAAAAYBlCJwAAAADAMoROAAAAAIBlCJ0AAAAAAMsQOgEAAAAAliF0AgAAAAAsQ+gEAAAAAFiG0AkAAAAAsAyhEwAAAABgGUInAAAAAMAyhE4AAAAAgGUInQAAAAAAyxA6AQAAAACWIXQCAAAAACxD6AQAAAAAWIbQCQAAAACwDKETAAAAAGAZQicAAAAAwDKETgAAAACAZQidAAAAAADLEDoBAAAAAJYhdAIAAAAALEPoBAAAAABYhtAJAAAAALAMoRMAAAAAYBlCJwAAAADAMoROAAAAAIBlCJ0AAAAAAMsQOgEAAAAAliF0AgAAAAAsQ+gEAAAAAFiG0AkAAAAAsAyhEwAAAABgGUInAAAAAMAyhE4AAAAAgGUInQAAAAAAyxA6AQAAAACWIXQCAAAAACxD6AQAAAAAWIbQCQAAAACwDKETAAAAAGAZQicAAAAAwDKETgAAAACAZQidAAAAAADLEDoBAAAAAJYhdAIAAAAALEPoRKqZPHmyChUqJB8fH1WsWFGbN2++7/QRERGqWLGifHx8VLhwYU2dOjWVKgUAAACQUgidSBULFy7Ua6+9psGDB2vPnj2qWbOmQkNDdezYMafTHzlyRE2aNFHNmjW1Z88eDRo0SH379tWiRYtSuXIAAAAAj4LQiVQxfvx4de3aVd26dVNwcLAmTJigwMBATZkyxen0U6dOVYECBTRhwgQFBwerW7du6tKli8aNG5fKlQMAAAB4FB6uLgDp361bt7Rr1y4NGDDAYXjDhg21ZcsWp/Ns3bpVDRs2dBjWqFEjTZ8+Xbdv35anp2eCeaKjoxUdHW3//fLly5KkK1euPOoq3Fdc9A1Ll4+UY3VbuBvtIu1IrXZBm0g7OFbAGavbRfzyjTGWvg7gCoROWO7cuXOKjY1VQECAw/CAgACdPn3a6TynT592On1MTIzOnTunPHnyJJhn7NixGjlyZILhgYGBj1A90pMsE1xdAR5HtAvcizYBZ1KrXVy9elVZsmRJnRcDUgmhE6nGZrM5/G6MSTDsQdM7Gx5v4MCBCgsLs/8eFxenCxcuKEeOHPd9HTi6cuWKAgMDdfz4cWXOnNnV5eAxQbuAM7QL3Is28fCMMbp69ary5s3r6lKAFEfohOX8/f3l7u6e4KpmZGRkgquZ8XLnzu10eg8PD+XIkcPpPN7e3vL29nYYljVr1ocv/F8uc+bMnDAgAdoFnKFd4F60iYfDFU6kV3QkBMt5eXmpYsWKCg8PdxgeHh6uatWqOZ0nJCQkwfRr165VpUqVnH6fEwAAAMDjidCJVBEWFqZp06ZpxowZOnjwoPr166djx46pR48eku7cGtuhQwf79D169NDff/+tsLAwHTx4UDNmzND06dPVv39/V60CAAAAgIfA7bVIFW3bttX58+c1atQonTp1SqVLl9aqVasUFBQkSTp16pTDMzsLFSqkVatWqV+/fpo0aZLy5s2rTz75RC1btnTVKvxreHt7a/jw4QluVca/G+0CztAucC/aBABnbIZ+mQEAAAAAFuH2WgAAAACAZQidAAAAAADLEDoBAAAAAJYhdAIAAAAALEPoBAAAAABYhtAJ/AvQSTWAB4mLi5MkRUVFubgSPC7i28TdeD8B8DAInUA6Fn/CcPPmTRdXgseJsxNJ/LvFxcXJzc1NP//8s1599VWdOnXK1SXBxeLbxIkTJ7RkyRItXbpUBw4ckM1mc3VpANIgQieQTsWfMOzZs0elSpXSsWPHXF0SHgPx7eKvv/7StGnTNGLECG3fvl1nzpxxdWlwkfg2sW/fPpUvX1558+ZVnjx5JHFV69/KGGP/EKJy5coaMmSI+vbtq0qVKumDDz7Q2bNnXV0igDSG0AmkQ3efRNasWVOtWrVSgQIFXF0WXCz+RPKXX35R5cqVNWPGDC1cuFCNGjVS//799cMPP7i6RKSy+GPFL7/8opCQEA0cOFCjR4+2j7927ZoLq4Or2Gw2XbhwQS+++KJeeuklbd26VZs3b9b777+vQYMGacSIETpx4oSrywSQhhA6gXTm7mBRrVo19enTR+PGjZMk3bp1S6dPn3ZxhXAVm82ma9eu6bXXXlOHDh20ceNGHTx4UFOnTtX58+c1ePBgrVu3ztVlIhW5ubnp2LFjCgkJUWhoqN5++21J0oABA9S4cWM1aNBAQ4YM4Xue/0LR0dG6ffu2QkNDlSlTJhUoUEC9e/fWt99+q2nTpumjjz5SXFwcV8MBJAmhE0hnbDabzp07p1atWql48eIaO3asJKlLly6qU6eOihQpoi5dumjlypUurhSuYIzRyZMnVaJECXl7e0uS2rVrp/79+yt79uwaN26c9u7d69oikao8PDwUEBAgSVq3bp2qVaumnTt3Kjg4WA0aNNCECRP04osvurhKpLbr16/r6NGjun79uiTp9u3biouL0zPPPKO5c+fqo48+0rJly/iOJ4AkIXQC6VBUVJQaNWokY4zee+89NWzYUKdPn1abNm306aef6tChQ/roo4+0efNmV5eKVGSMUWxsrPz9/RUZGSlJio2NlSTVrVtXPXr00JkzZ7RixQpJdDj0bxAXF6e8efNq/fr1Onz4sFq0aKHcuXNr3rx5+uijjzR69Ght2rRJK1as0Oeff+7qcpGKihYtqnbt2umtt97SH3/8IU9PT/sxpHXr1nrllVc0efJk3bhxg6udAB6I0AmkQ/nz51f//v0VGhqq999/X3Fxcfryyy/Vt29fde7cWZ999pn+/PNPRUREuLpUpCKbzaasWbPq6aef1oQJE7R//365u7vbg2doaKieffZZTZo0STdu3JCbG28R6Z2bm5tiY2NVsGBBLV26VE2bNtXLL79sv/IpSWXKlFHx4sX1999/u7BSWOXeD5fijweS1KlTJ+XKlUtvvfWWjhw5Ind3d/uVzVy5cunGjRvKkCEDVzsBPBBnFEA6VaBAAfXo0UMDBw7UgAEDlCNHDtlsNsXFxal06dIqVaoUt1GmY/Enkrdv37YPiz+ZfOedd1SpUiU1a9bMfiIZr1KlSgoICHCYD+mbu7u7YmJiFBQUpGnTpql27doO46Ojo5U9e3YVK1ZMEj3apifxHUkdPHhQw4YNk3SnPcTv/7Vq1dJLL72kc+fOqVevXjp48KD9w6hLly4pW7ZsunnzJm0CwAN5uLoAANaIi4tTUFCQunbtKj8/P/twNzc3RUdHS7oTMJD+xJ9I/vbbb5oyZYp69Oih4OBgubu728d9/vnn6tixo2rWrKlZs2apbNmyypUrl9auXStPT0+ucv6LxMTEyMPDQ9HR0cqUKVOCAPHee+/p2LFjqlu3riRxVSsdcXNz0+HDh1W3bl2dOXNGkZGRmjp1qjw9PXXr1i15eXmpc+fO8vX11Zw5c1SxYkXVq1dP0dHR2rZtmzZv3ixfX19XrwaANMBm+HgKSJOMMYme/MWfRF67dk0xMTHKmjWrw/ghQ4boyy+/1Pr161W0aNFUqBap7a+//tLTTz+tf/75R88++6zef/99FSlSxGGac+fOqXfv3tqwYYMyZ86svHnz6pdfftHGjRtVvnx51xSOVBUbGyt3d3cdOXJEDRo00IYNG+yPV1q/fr1mz56tVatWKTw8XBUqVHBxtUhpV65cUd++fXX16lU9/fTTevfdd9W0aVNNmzZNkuzBU5L++ecfLV++XHv37pW/v79eeOEFlSxZ0pXlA0hDuNIJpEHxV6tOnz6tbNmy2Xshle6cRHp4eOjo0aNq2bKlPvroIz399NOSpHnz5un777/XmjVrtHbtWgJnOhUVFaXJkyerVq1a6ty5s1q1aqXXXntNEyZMcAie/v7+WrBggZYvX64TJ07IZrOpYcOGKly4sAurR2pyd3fX33//raefflp169ZVYGCgJOnq1au6ePGirl27pk2bNql06dIurhRWcHNzU968efXUU0+pYcOGyp49u958801169ZN06ZNk5eXl27fvi1PT0/lzZtX3bt3d3XJANIornQCaUx84NyzZ48qVqyo1atXq2HDhg7THD16VFWrVrV/Yh1/RXTr1q2aMmWKBg4cqODgYFeUj1Rw8+ZNLV++XLGxsXr++ef1xx9/6KmnnlLNmjUdgmf8FXGkf/F3Rhw8eFBHjx6VzWZT2bJllTdvXj333HPKnTu3Jk2a5HD3RHR0tGJjY5UhQwYXVg6rxLeJa9euKWPGjJLuXPlcsmSJ3nrrLYcrnlFRUbp+/bpy5MjhypIBpGGETiANiQ+c+/btU82aNfXKK69o3LhxCaYbNmyY/vnnH33xxRcJbsG9+3YppF93n0hK0qFDh1SlShXVrFlTH3/8sQoXLixjjHbv3q2KFSu6sFKklkWLFql///7KlCmTsmTJosOHD2vDhg3y9vZWoUKFXF0eXCz+/eXatWtatGiRBgwYYA+ePXv2lDFGEydOlKenp6tLBZAGETqBNGb//v2qUqWKXn/9dY0aNUrGGB04cEAnTpxQ4cKF7T1Mxt8ShX83Y4zi4uLk7u6u3377TVWrVlXNmjX1wQcfaNKkSdq3b5+WLVuW4Hu/SF+2b9+uRo0a6f3339crr7yiH374QbVr19bIkSM1dOhQSff/njjSt/i/ffy/169f16JFizR48GC5u7vr5MmT2rJli5566ilXlwogjSJ0AmlIdHS0nn/+eS1ZssT+SIzQ0FCdPXtWu3fv1hNPPKEnn3xSs2bNcjiBAOI/hDh06JBq1KghY4yuXr2qrVu36sknn3R1ebDYjBkztGnTJs2ZM0fHjh1TjRo19J///EeffvqpJOny5cvKkiWLi6tEaou/xT7++BB/tVOSLly4oGeeeUYHDx7ke70AHhl94gNpiJeXlwYNGqQnnnhClSpVUoMGDeTp6amPPvpIhw4dUvfu3bV3717169dPEo82SM/u93lhTEyMpDu32F68eFGS5OnpqdjYWJUoUUINGjSQJO3evZvA+S9x9OhRXbt2TUeOHFGNGjUUGhqqiRMnSpJWrlypcePG6ebNmy6uEqkpvtO5I0eOKDg4WMeOHbMHztjYWE2YMEFbt27V+vXrCZwAHhmhE3iM3RssbDabKlasqC+//FKxsbG6ePGipkyZopo1a6pYsWLq3r276tSpo23btunKlSsuqhpWi4uLk81m0+nTp+3PXI13d+/FtWrV0i+//GIf5+bmphEjRmjBggVat26dnnjiidQuHakg/rhx6tQp3b59W5JUpkwZnThxQtWrV1fDhg312Wef2addvXq1Tp06Zb97Av8Od/dcXL16dXvPxdKdu2piYmK0Z88elStXzoVVAkgvCJ3AYyo+WFy+fFl//fWXTpw4oevXr8tms6lMmTKaM2eOxo4dq4CAAPv0np6eKliwoK5duyZ3d3cXrwGscHfvxXnz5lVERITDeHd3d3vvxeXLl1fNmjXt44wxql69uvbv389zONOp+Fvqly9friZNmmjVqlWSpOeee07ZsmXTuXPn9Mwzz+jGjRu6ePGiBg0apK+//lqvv/66/Pz8XFw9rBD/IcTBgwf1/fffa/Xq1frnn38kSf369VPz5s3tX8mIlyFDBo0ZM0ZlypRxSc0A0h++0wk8huKDxf79+/XKK6/owoULio6OVvPmzTVw4EDlyZPHflUi/naoeN27d9fVq1c1a9YseqlNZ1Ki92Kkf0uWLNGLL76oYcOGqUWLFipevLikO7dd16tXT2fOnNGFCxf0xBNP6K+//tKSJUtUoUIFF1cNK9FzMQBXI3QCj5n4KxWHDh1SzZo19dJLL6lVq1bauHGjlixZojfffFOtWrVKMN/58+c1btw4TZs2TZs2beLWyXSK3otxP2fOnFGDBg3UsWNHvf7664qJiVFsbKzWr1+vKlWqKEeOHIqIiNC+fftUrFgxlS5d2uG2SqQ/9FwM4HFA6AQeQ1euXFHHjh2VK1cu+3evJKlp06by8PDQ0qVLHaZfs2aNvvrqK23YsEHLli3jqkU6Re/FeJCjR48qNDRU06dPV9GiRfXFF18oPDxcP/74oypVqqThw4ercePGri4TqYieiwE8DvhOJ/AYunTpknLkyKHmzZtL+r/eSJ955hnFxsZKcuxkqEKFCqpdu7Z++OEHAmc6Ru/FeJCCBQvKw8NDnTt3VpkyZbRr1y77Yy8uXLig7du3u7pEpDJ6LgbwOPBwdQEAEipQoICef/551atXT9L/fW8zQ4YMun79usO0Fy9eVK5cudSpUydCRjpz75XKu3sv7ty5sy5evKhZs2YpX758ku4Ejj///NPee3HmzJldVTpSQXz7+O2333Tr1i0ZY1SuXDnt3LlT48ePV44cOdS6dWtlypRJHh4eKlu2rP1YwlXw9Cn+73rq1Cn5+/vL09NTZcqU0erVq1W9enU1adJEn332mYwx9p6Lb968Sc/FACzHlU7gMRP/5h8fOO9+WPe1a9d04cIFe8+2o0ePVrdu3eyPRUD6Qe/FeBCbzaZvv/1WtWrVUrNmzdSyZUu9//778vb21sCBA/XKK68oW7ZsunXrlgYPHqyNGzeqbdu29nmRvtBzMYDHGVc6gcdE/AlDfID09vaWdOcqZ/y4zJkzK2PGjHJzc9PQoUP13nvvafv27XQYk84kpffiJ554Qk888YT9A4n4fw8ePKiyZcvSJtKx+OPBhQsX7MeBoKAgbd++XUOGDNG1a9c0atQoSXd6sp02bZr279+v8PBwe0+2SH9sNptDz8XBwcGS7jxGaeXKlapXr57eeOMNh56LV69ebZ8OAKxE6AQeE/GfUH/yyScyxug///mP+vbtax8nST4+PsqePbsGDRqk8ePHa+vWrXyHM50xxsjNzU2HDh1S3bp1E/Re/OOPP6pVq1YJHpUT33vx4sWLtWnTJh6Xk47ZbDatX79e69atU/369dW+fXt5eXnpqaeeUqZMmfTf//5Xbm5uGjFihCpXrqw//vhDEyZMUNGiRV1dOix05swZDRs2TCNHjrT3XBwdHW3vuTgiIoKeiwG4DKETeExs3bpVHTt2VLt27XT79m31799fv//+u8aNGycfHx9Jd76/uXLlSm3cuFFbtmzRk08+6eKqkdJsNpuuXLmiAQMG6Nlnn9WHH34oSQoJCdGPP/6oL7/8MsEjc+7uvXjt2rU8Liedi46O1saNG/XBBx+ofPny9g8YMmbMqI4dO0qS+vfvrxs3buj9999X//79uZ32X+DmzZu6ffu2QkJCFBkZmWjPxbVq1XJ1qQD+hfhOJ+BCd/dAGx0drf79+2vy5Mn64osvtHTpUs2YMUNhYWH2ngWDgoJUsWJF7dixg8CZjtF7Me7H29tbL7/8soYOHardu3drypQp9nEZM2ZUp06dNHr0aM2YMUPnzp1zYaVITfRcDOBxxpVOwEXiv5f1008/6c8//9TSpUtVunRp+/jQ0FAtWrRIzz33nNzc3PTxxx+rfv36Kl++vPz9/V1YOaxG78W4W/yx4uzZs7p+/boCAgIUFBSkN954Qzdv3tQbb7whNzc3de/eXZLk5+enXr16qWvXrsqWLZuLq4cV6LkYQFpD6ARcJP47nM8884wqVKigPXv26PTp02rfvr2KFCki6U7wXLJkiUJDQ+Xh4aEJEyYQONO5+E6EHtR7sZubm0aPHq29e/dqwYIF8vDgcJ4exQeEJUuWaOTIkbpy5YqyZMmiBg0aqF+/fnrrrbfk4eGhN954Q+7u7urWrZukOx9QZMiQwcXVwyrxPRe/+uqr8vb2lpeXl1555RW9+eabGjhwoH26GzduaPjw4dq4caPefvtt+7wAkNo4SwFS2d3PUZszZ46mTZum//znP/r555/VtGlTjRgxQu+88469g4dGjRpp7dq1yp8/v4srh5XovRj3iv9wYd26dXrxxRc1evRode7cWe+8844mTpyoSpUqqXXr1nr11Vfl5uamV155RR4eHurUqZOrS4dF6LkYQFpF6ARSmc1m0w8//KCpU6fq8uXLqlOnjvz9/VW3bl1t2LBBderUkTFG7777rj1o1q9f38VVw2r0XgxJ+vLLL3X16lX16tVLbm5uun37tr7++mu98sor6tevnyIjI/XNN9+oc+fOat26tSQpICBAffr0kZeXl0JCQly8BrASPRcDSKsInYALxMXFad26dbp06ZL279+vQoUKSbrTQ+mmTZvUoEEDXblyRVOmTFG+fPlcXC1SA70X4/r165ozZ46uX7+uDBkyqFOnTvL09FRkZKTq16+vs2fPqkKFCmrWrJk+/fRTSdKyZcvk5+enevXqaeDAgXJ3d3fxWsBK9FwMIK2i91rAYsYYe4+j586d05UrV1S7dm1t2bJFgYGBmjZtmnbt2mWfvmrVqlq1apV++uknThbSOXovxt38/Pw0Z84c5c+fX7Nnz9YXX3whScqcObPGjx+vKlWqqEWLFpo0aZJsNptu3LihBQsWaMeOHYqNjSVw/gvQczGAtMpm7j7rAZBiVq1apXz58qlcuXKSpMWLF+u9997T2bNnVbp0afXs2VMlS5ZU/fr19eSTT2rAgAGqWLGiff6oqCj7FS6kP4n1Xjx06FD7NN9//72ee+45de3aVR9//LHc3d117tw5OpNKh4wxiomJkaenpw4cOKD+/fvr0qVL6t+/v0qVKqX27dsrMjJSJ06csM8zePBgzZ07V+vXr+f2yXTKWc/Fvr6+unHjhkaNGqVPP/1UH374ob3nYulO50HR0dH0XAzgsULoBCxw5swZhYSEqHbt2hoyZIiioqIUEhKiN998Ux4eHjp69KimTZumadOmqWbNmmrQoIGqVKmi//73v6pSpYokurX/N7i39+KaNWtqxowZ9t6LJWnNmjUKDQ1V3759NWHCBNcVC0vF7+9ff/21Fi1apOPHj2vv3r3Kly+fXn/9dWXMmFEDBw6Uv7+/ihUrptjYWEVERCg8PJzv9aZTD+q52NvbWx9++KE++eQTjR8/3t5zMQA8jgidgEV2796t7t27q0qVKsqaNauio6P1wQcfSJKuXLmiOXPmKCwsTN9//71y5cqlp59+Wi1bttSkSZPsPZci/bm79+K+ffsqNDTUoffiVq1aOfReLEnr1q1T/vz5VbJkSRdWDqtt375ddevW1cSJE1W9enX7I1BsNpvat2+v2rVra/Lkybp48aIKFSqk9u3bq1ixYq4uGxa4u+fiFi1aOPRc/Omnn2r27Nlq3bq1Tp06pSlTpmjMmDGaMWMGPRcDeGwROgEL7d69Wz179tSZM2ccOv+QpMuXL+u1115TVFSU5s+fry1btihXrlzcJvcvEN978blz5/TZZ5/ZO5LaunWr6tSpo1atWjn0Xox/h88//1wfffSRdu7cKT8/P0nSiRMn1K5dO505c0bvv/++nn32WRdXCavc3XOxJN2+fVuvvvqqMmbMqPHjxysyMlJVqlRRkyZNNGnSJEl3wun58+f12WefqXXr1ipRooQrVwEAEkVHQoCFnnzySX3xxRf2bu737t1rH5clSxbly5dPBw4cUFRUlKpVq0bg/JeI771406ZN2r9/v314fO/FS5cuVa9evXTy5EkXVonU5uvrq9jYWF27dk3SndCRP39+TZkyRadPn9bQoUM1e/ZsSY6dUCHti++5eO7cuZo1a5Yk2Xsurlq1qr3n4oYNGzr0XLxx40blzJlTAwcOJHACeKwROgGLlS1bVsuWLZOnp6c++eQTh+B57tw55cyZ0967LdIfei9GUoWEhOj48eP2q1ienp6SpFu3bqlixYoqW7as6tatK0m0jXSGnosBpHfcXgukkj179qhDhw66fv26atWqJW9vb3377bdat26dypcv7+rykMLovRgPY+7cuerSpYveeOMNdevWTVmzZtX48eN1/PhxffLJJ8qcObOrS0QKo+diAP8GhE4gFf3yyy967rnndOvWLfXs2VPPP/+8goKCXF0WUhi9F+NhGWM0f/58de/eXf7+/nJzc9OlS5cUHh7Os1nTKXouBvBvQOgEUtmuXbs0cOBAzZs3Tzlz5nR1ObAIvRfjURw9elQ///yzbt68qSpVqqhgwYKuLgkWoudiAOkdoRNwAW6d/Heg92IASUHPxQDSOzoSAlyAwPnvQO/FAJKCnosBpHeETgCwEL0XA3gQei4GkN5xey0ApAJ6LwZwP/RcDCA9I3QCQCqh92IAiaHnYgDpGaETAFIRvRcDuB96LgaQHhE6ASCV0XsxAAD4NyF0AgAAAAAsQ++1AAAAAADLEDoBAAAAAJYhdAIAAAAALEPoBAAAAABYhtAJAAAAALAMoRMAAAAAYBlCJwAAAADAMoROAEC6Vrt2bb322mspvtwRI0aofPnyKb7clFCwYEFNmDDB1WUAACCJ0AkAcKFOnTrJZrOpR48eCcb16tVLNptNnTp1StKyNm3aJJvNpkuXLqVskY/AqsALAEBaQugEALhUYGCgFixYoJs3b9qHRUVFaf78+SpQoIALKwMAACmB0AkAcKknn3xSBQoU0OLFi+3DFi9erMDAQFWoUME+zBij999/X4ULF5avr6/KlSunb7/9VpJ09OhR1alTR5KULVu2BFdI4+Li9Oabbyp79uzKnTu3RowY4VDDsWPH9MwzzyhjxozKnDmz2rRpozNnzjhM8+677yogIECZMmVS165dFRUVdd/16tSpkyIiIvTxxx/LZrPJZrPp6NGjkqSIiAhVrlxZ3t7eypMnjwYMGKCYmBj7vLVr11bv3r3Vu3dvZc2aVTly5NCQIUNkjEnydr3bzJkzlSVLFoWHhz/U/AAAPApCJwDA5Tp37qyZM2faf58xY4a6dOniMM2QIUM0c+ZMTZkyRb/++qv69eunF198UREREQoMDNSiRYskSYcOHdKpU6f08ccf2+edPXu2/Pz8tH37dr3//vsaNWqUPYAZY9SiRQtduHBBERERCg8P1+HDh9W2bVv7/F9//bWGDx+ut99+Wzt37lSePHk0efLk+67Txx9/rJCQEL388ss6deqUTp06pcDAQJ08eVJNmjTRU089pX379mnKlCmaPn26xowZ4zD/7Nmz5eHhoe3bt+uTTz7RRx99pGnTpiV7244bN079+/fXmjVr1KBBg2TPDwDAo7KZh/3YFACAR9SpUyddunRJ06ZNU/78+fXbb7/JZrOpZMmSOn78uLp166asWbNq0qRJ8vf314YNGxQSEmKfv1u3brpx44a++uorbdq0SXXq1NHFixeVNWtW+zS1a9dWbGysNm/ebB9WuXJl1a1bV++++67Cw8MVGhqqI0eOKDAwUJJ04MABPfHEE/rpp5/01FNPqVq1aipXrpymTJliX0bVqlUVFRWlvXv3Jrp+tWvXVvny5R069Rk8eLAWLVqkgwcPymazSZImT56st956S5cvX5abm5tq166tyMhI/frrr/ZpBgwYoGXLlunAgQMP3K4FCxbUa6+9pjNnzmj27Nlas2aNypQp88D5AACwAlc6AQAu5+/vr6ZNm2r27NmaOXOmmjZtKn9/f/v4AwcOKCoqSg0aNFDGjBntP3PmzNHhw4cfuPyyZcs6/J4nTx5FRkZKkg4ePKjAwEB74JSkUqVKKWvWrDp48KB9mrvDriSH3zdv3uxQ17x58xKtJX5Z8WFSkqpXr65r167pxIkT9mFVq1Z1mCYkJER//PGHYmNjH7i+kvThhx/qs88+0//+9z8CJwDApTxcXQAAAJLUpUsX9e7dW5I0adIkh3FxcXGSpJUrVypfvnwO47y9vR+4bE9PT4ffbTabfZnGGIdwFy+x4c5UqlTJ4YpnQEBAotM6W278TUdJfb2kqFmzplauXKmvv/5aAwYMSLHlAgCQXIROAMBjoXHjxrp165YkqVGjRg7jSpUqJW9vbx07dky1atVyOr+Xl5ckJflK4N3LPnbsmI4fP+5we+3ly5cVHBwsSQoODta2bdvUoUMH+3zbtm2z/9/X11dFixZ1WtO99ZQqVUqLFi1yCJ9btmxRpkyZHAL13cuP/71YsWJyd3dP0npVrlxZffr0UaNGjeTu7q433ngjSfMBAJDSCJ0AgMeCu7u7/XbWe4NVpkyZ1L9/f/Xr109xcXGqUaOGrly5oi1btihjxozq2LGjgoKCZLPZtGLFCjVp0kS+vr7KmDHjA1+3fv36Klu2rF544QVNmDBBMTEx6tWrl2rVqqVKlSpJkv773/+qY8eOqlSpkmrUqKF58+bp119/VeHChe+77IIFC2r79u06evSoMmbMqOzZs6tXr16aMGGC+vTpo969e+vQoUMaPny4wsLC5Ob2f996OX78uMLCwtS9e3ft3r1bEydO1IcffpisbRoSEqLvv/9ejRs3loeHh/r165es+QEASAl8pxMA8NjInDmzMmfO7HTc6NGjNWzYMI0dO1bBwcFq1KiRli9frkKFCkmS8uXLp5EjR2rAgAEKCAiw36r7IDabTUuWLFG2bNn09NNPq379+ipcuLAWLlxon6Zt27YaNmyY3nrrLVWsWFF///23evbs+cBl9+/fX+7u7ipVqpRy5sypY8eOKV++fFq1apV++uknlStXTj169FDXrl01ZMgQh3k7dOigmzdvqnLlynr11VfVp08fvfLKK0lap7tVr15dK1eu1NChQ/XJJ58ke34AAB4VvdcCAPCYcdbrLQAAaRVXOgEAAAAAliF0AgCQhtz7eJZ7fwAAeNxwey0AAGnIzZs3dfLkyUTHO+tFFwAAVyJ0AgAAAAAsw+21AAAAAADLEDoBAAAAAJYhdAIAAAAALEPoBAAAAABYhtAJAAAAALAMoRMAAAAAYBlCJwAAAADAMoROAAAAAIBl/h8rPow/Vd3OGgAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Exiting. Goodbye!\n"
     ]
    }
   ],
   "source": [
    "\"\"\"\n",
    "Task 3: Retrieval-Augmented Generation (RAG) Pipeline\n",
    "\n",
    "This revised script:\n",
    "- Prints each question and answer in the terminal/console for 5 example queries (BM25 & dense, top_k=5/10).\n",
    "- Shows bar charts (token length, 'contains_answer' count, confidence).\n",
    "- In interactive mode, it does the same for any user question, again printing question+answers and showing charts.\n",
    "\"\"\"\n",
    "\n",
    "import sys\n",
    "from Bio import Entrez\n",
    "import chromadb\n",
    "from sentence_transformers import SentenceTransformer\n",
    "from rank_bm25 import BM25Okapi\n",
    "import nltk\n",
    "from nltk.tokenize import word_tokenize\n",
    "from transformers import AutoTokenizer, AutoModelForQuestionAnswering, pipeline\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# 1) ENV SETUP\n",
    "nltk.download(\"punkt\")\n",
    "Entrez.email = \"choksi.pr@northeastern.edu\"\n",
    "\n",
    "# If you want GPU usage, set USE_GPU = True, else it uses CPU\n",
    "USE_GPU = False\n",
    "DEVICE_ID = 0 if USE_GPU else -1\n",
    "\n",
    "# 2) CHROMADB INIT\n",
    "chroma_client = chromadb.PersistentClient(path=\"chroma_store\")\n",
    "collection_name = \"scientific_papers_interactive\"\n",
    "collection = chroma_client.get_or_create_collection(collection_name)\n",
    "\n",
    "# 3) SENTENCE TRANSFORMER\n",
    "embedding_model = SentenceTransformer(\"all-MiniLM-L6-v2\")\n",
    "\n",
    "# ---------------------------\n",
    "# PUBMED FETCH & INDEX\n",
    "# ---------------------------\n",
    "def fetch_pubmed_data(query, max_results=10):\n",
    "    handle = Entrez.esearch(db=\"pubmed\", term=query, retmax=max_results)\n",
    "    record = Entrez.read(handle)\n",
    "    handle.close()\n",
    "\n",
    "    id_list = record.get(\"IdList\", [])\n",
    "    if not id_list:\n",
    "        print(\"No PubMed articles found for query:\", query)\n",
    "        return []\n",
    "\n",
    "    handle = Entrez.efetch(db=\"pubmed\", id=id_list, rettype=\"xml\")\n",
    "    papers = Entrez.read(handle)\n",
    "    handle.close()\n",
    "\n",
    "    results = []\n",
    "    for paper in papers.get('PubmedArticle', []):\n",
    "        title = paper['MedlineCitation']['Article']['ArticleTitle']\n",
    "        abstract = paper['MedlineCitation']['Article'].get('Abstract', {}).get('AbstractText', [\"\"])[0]\n",
    "        results.append({\n",
    "            \"id\": paper['MedlineCitation']['PMID'],\n",
    "            \"title\": title,\n",
    "            \"abstract\": abstract,\n",
    "            \"text\": abstract\n",
    "        })\n",
    "    return results\n",
    "\n",
    "def index_papers(papers):\n",
    "    for paper in papers:\n",
    "        emb = embedding_model.encode(paper[\"text\"]).tolist()\n",
    "        collection.add(\n",
    "            ids=[paper[\"id\"]],\n",
    "            embeddings=[emb],\n",
    "            metadatas=[{\"title\": paper[\"title\"], \"abstract\": paper[\"abstract\"]}],\n",
    "            documents=[paper[\"text\"]]\n",
    "        )\n",
    "\n",
    "def maybe_fetch_and_index_papers(query, max_results=10):\n",
    "    existing_count = collection.count()\n",
    "    if existing_count > 0:\n",
    "        print(f\"\\n>>> ChromaDB collection already has {existing_count} documents.\")\n",
    "        choice = input(\"Skip fetching from PubMed? (y/n) [default: y] >> \").strip().lower()\n",
    "        if choice in [\"n\", \"no\"]:\n",
    "            print(\"Deleting existing docs and fetching new ones...\")\n",
    "            collection.delete()\n",
    "            new_papers = fetch_pubmed_data(query, max_results)\n",
    "            if new_papers:\n",
    "                index_papers(new_papers)\n",
    "            else:\n",
    "                print(\"No new papers fetched.\")\n",
    "        else:\n",
    "            print(\"Skipping PubMed fetch, using existing data.\")\n",
    "    else:\n",
    "        print(\"ChromaDB collection is empty. Fetching new documents from PubMed...\")\n",
    "        new_papers = fetch_pubmed_data(query, max_results)\n",
    "        if new_papers:\n",
    "            index_papers(new_papers)\n",
    "        else:\n",
    "            print(\"No papers fetched from PubMed.\")\n",
    "\n",
    "maybe_fetch_and_index_papers(\"AI in healthcare\", max_results=10)\n",
    "\n",
    "all_docs = collection.get()\n",
    "documents = all_docs.get(\"documents\", [])\n",
    "if not documents:\n",
    "    print(\"No documents in ChromaDB. Exiting.\")\n",
    "    sys.exit(0)\n",
    "\n",
    "tokenized_docs = [word_tokenize(doc.lower()) for doc in documents]\n",
    "bm25 = BM25Okapi(tokenized_docs)\n",
    "\n",
    "def retrieve_bm25(query, top_k=5):\n",
    "    t_query = word_tokenize(query.lower())\n",
    "    scores = bm25.get_scores(t_query)\n",
    "    top_n_indices = sorted(range(len(scores)), key=lambda i: scores[i], reverse=True)[:top_k]\n",
    "    return [documents[i] for i in top_n_indices]\n",
    "\n",
    "def retrieve_dense(query, top_k=5):\n",
    "    emb = embedding_model.encode(query).tolist()\n",
    "    results = collection.query(query_embeddings=[emb], n_results=top_k)\n",
    "    print(\"\\nDense Retrieval Results:\", results)\n",
    "    if not results.get(\"documents\"):\n",
    "        return []\n",
    "    return results[\"documents\"][0]\n",
    "\n",
    "# QA MODEL\n",
    "from transformers import AutoTokenizer, AutoModelForQuestionAnswering, pipeline\n",
    "\n",
    "tokenizer = AutoTokenizer.from_pretrained(\"distilbert-base-uncased-distilled-squad\")\n",
    "model = AutoModelForQuestionAnswering.from_pretrained(\"distilbert-base-uncased-distilled-squad\")\n",
    "qa_pipeline = pipeline(\n",
    "    \"question-answering\",\n",
    "    model=model,\n",
    "    tokenizer=tokenizer,\n",
    "    device=DEVICE_ID  # 0 => GPU, -1 => CPU\n",
    ")\n",
    "\n",
    "print(f\"\\nUsing device={DEVICE_ID} ('cuda:0' if 0, 'cpu' if -1)\\n\")\n",
    "\n",
    "# EVALUATION\n",
    "def check_retrieval_effectiveness(answer, retrieved_docs):\n",
    "    ans_lower = answer.lower()\n",
    "    for doc in retrieved_docs:\n",
    "        if ans_lower in doc.lower():\n",
    "            return True\n",
    "    return False\n",
    "\n",
    "def evaluate_response(query, retrieval_method=\"dense\", top_k=5):\n",
    "    if retrieval_method == \"bm25\":\n",
    "        docs = retrieve_bm25(query, top_k)\n",
    "    else:\n",
    "        docs = retrieve_dense(query, top_k)\n",
    "\n",
    "    if not docs:\n",
    "        return {\n",
    "            \"question\": query,\n",
    "            \"retrieval_method\": retrieval_method,\n",
    "            \"top_k\": top_k,\n",
    "            \"answer\": \"No documents retrieved.\",\n",
    "            \"token_length\": 0,\n",
    "            \"contains_answer\": False,\n",
    "            \"confidence_score\": 0.0\n",
    "        }\n",
    "\n",
    "    context = \" \".join(docs)\n",
    "    result = qa_pipeline({\"question\": query, \"context\": context})\n",
    "    answer_text = result[\"answer\"]\n",
    "    confidence = result.get(\"score\", 0.0)\n",
    "\n",
    "    return {\n",
    "        \"question\": query,\n",
    "        \"retrieval_method\": retrieval_method,\n",
    "        \"top_k\": top_k,\n",
    "        \"answer\": answer_text,\n",
    "        \"token_length\": len(answer_text.split()),\n",
    "        \"contains_answer\": check_retrieval_effectiveness(answer_text, docs),\n",
    "        \"confidence_score\": confidence\n",
    "    }\n",
    "\n",
    "# 5 EXAMPLE TEST QUERIES\n",
    "example_queries = [\n",
    "    \"How does AI help in drug discovery?\",\n",
    "    \"How does AI help in diagnostics?\",\n",
    "    \"What are the benefits of machine learning in healthcare?\",\n",
    "    \"How is deep learning used in medical imaging?\",\n",
    "    \"Does artificial intelligence improve patient outcomes?\"\n",
    "]\n",
    "METHODS = [\"bm25\", \"dense\"]\n",
    "TOP_K_VALUES = [5, 10]\n",
    "\n",
    "results = []\n",
    "for q_ in example_queries:\n",
    "    for rm_ in METHODS:\n",
    "        for tk_ in TOP_K_VALUES:\n",
    "            results.append(evaluate_response(q_, rm_, tk_))\n",
    "\n",
    "df_fixed = pd.DataFrame(results)\n",
    "print(\"\\n--- RESULTS FOR 5 EXAMPLE QUERIES (TABLE) ---\\n\")\n",
    "print(df_fixed)\n",
    "\n",
    "# Print Q&A in a more readable console format\n",
    "print(\"\\n--- DETAILED PRINT OF Q&A ---\\n\")\n",
    "for idx, row in df_fixed.iterrows():\n",
    "    print(f\"Q: {row['question']}\")\n",
    "    print(f\"Method={row['retrieval_method']} | top_k={row['top_k']}\")\n",
    "    print(f\"Answer: {row['answer']}\")\n",
    "    print(f\"Token Length: {row['token_length']}, Contains Answer: {row['contains_answer']}, Confidence: {row['confidence_score']:.3f}\")\n",
    "    print(\"-\" * 60)\n",
    "\n",
    "# GROUP & CHARTS\n",
    "grouped_fixed = (\n",
    "    df_fixed.groupby([\"retrieval_method\", \"top_k\"])\n",
    "            .agg({\n",
    "                \"token_length\": \"mean\",\n",
    "                \"contains_answer\": \"sum\",\n",
    "                \"confidence_score\": \"mean\"\n",
    "            })\n",
    "            .reset_index()\n",
    ")\n",
    "\n",
    "# (1) Average Token Length\n",
    "plt.figure()\n",
    "plt.bar(range(len(grouped_fixed)), grouped_fixed[\"token_length\"])\n",
    "plt.xticks(\n",
    "    ticks=range(len(grouped_fixed)),\n",
    "    labels=[f\"{rm}-{tk}\" for rm, tk in zip(grouped_fixed[\"retrieval_method\"], grouped_fixed[\"top_k\"])],\n",
    "    rotation=45,\n",
    "    ha=\"right\"\n",
    ")\n",
    "plt.title(\"5 Example Queries: Average Token Length (by Method & top_k)\")\n",
    "plt.xlabel(\"Method-top_k\")\n",
    "plt.ylabel(\"Avg. Token Length\")\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# (2) Count of 'Contains Answer'\n",
    "plt.figure()\n",
    "plt.bar(range(len(grouped_fixed)), grouped_fixed[\"contains_answer\"])\n",
    "plt.xticks(\n",
    "    ticks=range(len(grouped_fixed)),\n",
    "    labels=[f\"{rm}-{tk}\" for rm, tk in zip(grouped_fixed[\"retrieval_method\"], grouped_fixed[\"top_k\"])],\n",
    "    rotation=45,\n",
    "    ha=\"right\"\n",
    ")\n",
    "plt.title(\"5 Example Queries: Count of 'Contains Answer' (by Method & top_k)\")\n",
    "plt.xlabel(\"Method-top_k\")\n",
    "plt.ylabel(\"# Found In Docs\")\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# (3) Confidence\n",
    "plt.figure()\n",
    "plt.bar(range(len(grouped_fixed)), grouped_fixed[\"confidence_score\"])\n",
    "plt.xticks(\n",
    "    ticks=range(len(grouped_fixed)),\n",
    "    labels=[f\"{rm}-{tk}\" for rm, tk in zip(grouped_fixed[\"retrieval_method\"], grouped_fixed[\"top_k\"])],\n",
    "    rotation=45,\n",
    "    ha=\"right\"\n",
    ")\n",
    "plt.title(\"5 Example Queries: Average Confidence Score (by Method & top_k)\")\n",
    "plt.xlabel(\"Method-top_k\")\n",
    "plt.ylabel(\"Avg. Confidence Score\")\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# INTERACTIVE\n",
    "print(\"\\n--- INTERACTIVE MODE (TEST ALL COMBOS) ---\")\n",
    "while True:\n",
    "    user_input = input(\"\\nEnter your question (or 'exit'/'quit'/'esc' to stop): \").strip()\n",
    "    if user_input.lower() in [\"exit\", \"quit\", \"esc\"]:\n",
    "        print(\"Exiting. Goodbye!\")\n",
    "        break\n",
    "\n",
    "    combos_results = []\n",
    "    for rm in METHODS:\n",
    "        for tk_val in TOP_K_VALUES:\n",
    "            combos_results.append(evaluate_response(user_input, rm, tk_val))\n",
    "\n",
    "    df_interactive = pd.DataFrame(combos_results)\n",
    "    print(\"\\n--- RESULTS FOR YOUR QUESTION (TABLE) ---\\n\")\n",
    "    print(df_interactive)\n",
    "\n",
    "    # Print Q&A in detail\n",
    "    print(\"\\n--- DETAILED PRINT OF Q&A ---\\n\")\n",
    "    for idx, row in df_interactive.iterrows():\n",
    "        print(f\"Q: {row['question']}\")\n",
    "        print(f\"Method={row['retrieval_method']} | top_k={row['top_k']}\")\n",
    "        print(f\"Answer: {row['answer']}\")\n",
    "        print(f\"Token Length: {row['token_length']}, Contains Answer: {row['contains_answer']}, Confidence: {row['confidence_score']:.3f}\")\n",
    "        print(\"-\" * 60)\n",
    "\n",
    "    # Now group & plot the bar charts\n",
    "    grouped_int = (\n",
    "        df_interactive.groupby([\"retrieval_method\", \"top_k\"])\n",
    "                      .agg({\n",
    "                          \"token_length\": \"mean\",\n",
    "                          \"contains_answer\": \"sum\",\n",
    "                          \"confidence_score\": \"mean\"\n",
    "                      })\n",
    "                      .reset_index()\n",
    "    )\n",
    "\n",
    "    # (A) token_length\n",
    "    plt.figure()\n",
    "    plt.bar(range(len(grouped_int)), grouped_int[\"token_length\"])\n",
    "    plt.xticks(\n",
    "        ticks=range(len(grouped_int)),\n",
    "        labels=[f\"{rm}-{tk}\" for rm, tk in zip(grouped_int[\"retrieval_method\"], grouped_int[\"top_k\"])],\n",
    "        rotation=45,\n",
    "        ha=\"right\"\n",
    "    )\n",
    "    plt.title(f\"Interactive - Avg. Token Length for question: '{user_input}'\")\n",
    "    plt.xlabel(\"Method-top_k\")\n",
    "    plt.ylabel(\"Avg. Token Length\")\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "\n",
    "    # (B) contains_answer\n",
    "    plt.figure()\n",
    "    plt.bar(range(len(grouped_int)), grouped_int[\"contains_answer\"])\n",
    "    plt.xticks(\n",
    "        ticks=range(len(grouped_int)),\n",
    "        labels=[f\"{rm}-{tk}\" for rm, tk in zip(grouped_int[\"retrieval_method\"], grouped_int[\"top_k\"])],\n",
    "        rotation=45,\n",
    "        ha=\"right\"\n",
    "    )\n",
    "    plt.title(f\"Interactive - Count of 'Contains Answer' for question: '{user_input}'\")\n",
    "    plt.xlabel(\"Method-top_k\")\n",
    "    plt.ylabel(\"# Found In Docs\")\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "\n",
    "    # (C) confidence_score\n",
    "    plt.figure()\n",
    "    plt.bar(range(len(grouped_int)), grouped_int[\"confidence_score\"])\n",
    "    plt.xticks(\n",
    "        ticks=range(len(grouped_int)),\n",
    "        labels=[f\"{rm}-{tk}\" for rm, tk in zip(grouped_int[\"retrieval_method\"], grouped_int[\"top_k\"])],\n",
    "        rotation=45,\n",
    "        ha=\"right\"\n",
    "    )\n",
    "    plt.title(f\"Interactive - Avg. Confidence Score for question: '{user_input}'\")\n",
    "    plt.xlabel(\"Method-top_k\")\n",
    "    plt.ylabel(\"Confidence Score\")\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### **Observations and Conclusion**\n",
    "\n",
    "#### **Observations:**\n",
    "1. **Retrieval Method Comparison (BM25 vs Dense)**\n",
    "   - BM25 tends to retrieve **longer and more interpretable answers**, while Dense retrieval occasionally provides **shorter or vague responses**.\n",
    "   - In some cases, BM25 answers are **consistent across different top_k values**, whereas Dense retrieval results **vary significantly** when increasing top_k.\n",
    "\n",
    "2. **Answer Quality and Relevance**\n",
    "   - Some retrieved answers, such as *\"artificial intelligence\"* or *\"Biomarker\"*, are **overly generic and lack specific insights**.\n",
    "   - The **confidence scores** for many responses are **low (<0.5)**, indicating uncertainty in retrieval accuracy.\n",
    "   - Responses related to **Generative AI for image classification** provide reasonable detail, but some retrieved answers (e.g., *\"patch-clamp recordings and molecular dynamic simulations\"*) seem **out of context**.\n",
    "\n",
    "3. **Token Length and Answer Specificity**\n",
    "   - Shorter answers (**1-2 tokens**) often lack specificity and **may not provide useful information** (e.g., *\"AI\"*, *\"Biomarker\"*).\n",
    "   - Longer answers (**5+ tokens**) tend to be **more meaningful and informative**, but **can still lack precision** (e.g., *\"innovative tools and technologies, including artificial intelligence\"*).\n",
    "\n",
    "4. **Class Imbalance in Confidence Scores**\n",
    "   - There is a **significant variance in confidence scores**, even for similar questions and retrieval methods.\n",
    "   - Some responses have **high confidence but poor relevance**, while others with **lower confidence scores appear more accurate**.\n",
    "\n",
    "5. **Top-K Effect**\n",
    "   - Increasing **top_k** does not always improve answer quality. In some cases, the retrieved answers remain the same (**BM25**), while for **Dense retrieval**, there are noticeable shifts in answer selection.\n",
    "\n",
    "#### **Conclusion & Recommendations:**\n",
    "1. **BM25 is More Stable**  \n",
    "   - BM25 provides **more stable responses** across different **top_k values**, making it a reliable choice for structured retrieval tasks.\n",
    "   - However, it sometimes retrieves **generalized answers** that lack **depth**.\n",
    "\n",
    "2. **Dense Retrieval Needs Refinement**  \n",
    "   - Dense retrieval produces **more varied answers**, but some results appear **unrelated or out of context**.\n",
    "   - Using **hybrid retrieval (BM25 + Dense)** could **balance stability and contextual richness**.\n",
    "\n",
    "3. **Improve Answer Specificity**  \n",
    "   - Many responses are **too short or too vague**, reducing their usefulness.\n",
    "   - Implementing **answer re-ranking** based on contextual similarity and **fine-tuning embeddings** could enhance response relevance.\n",
    "\n",
    "4. **Confidence Scores Do Not Always Indicate Accuracy**  \n",
    "   - Some low-confidence responses are actually **better answers**, while some high-confidence ones are **irrelevant**.\n",
    "   - A **manual review or an additional validation step** could help filter out incorrect but high-confidence responses.\n",
    "\n",
    "5. **Adaptive Top-K Strategies Needed**  \n",
    "   - Increasing **top_k** does not consistently improve retrieval performance.\n",
    "   - A **dynamic top_k selection** based on **question complexity** could optimize the retrieval process.\n",
    "\n",
    "**Final Takeaway:**  \n",
    "The retrieval pipeline needs **hybrid optimization (BM25 + Dense), better re-ranking, and improved context filtering** to ensure **specific, relevant, and high-confidence answers**."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
